Canvassing for Opinion - aka "Blairs Brain on Cannabis"

DIAGNOSTIC INVERSION AND THE 2020 REFERENDUM

2026-07-31T00:09:21.754+12:00

MildGreens Initiative — Briefing Note Christchurch, New Zealand DIAGNOSTIC INVERSION AND THE 2020 REFERENDUM: WHY "NOT UP FOR DISCUSSION" IS A CATEGORY ERROR, NOT A POSITION 1. The mechanism Diagnostic inversion describes a specific and recurring error in drug policy discourse: the relabelling of prohibition-market harms as drug harms. Violence associated with unregulated supply chains, contamination from unregulated production, the criminal records generated by enforcement rather than by any pharmacological event, the enforcement expenditure itself, all of these are artefacts of a particular market design (illegal, unregulated, untaxed) rather than properties of the substance being prohibited. When these costs are attributed to the drug rather than to the policy architecture surrounding it, the diagnosis is wrong before any remedy is proposed. A policy response built on a misdiagnosis will, definitionally, treat the wrong variable. This is not a rhetorical flourish. It is falsifiable in the ordinary sense: where a jurisdiction has altered the market architecture while holding the substance constant (regulated retail replacing illicit supply, as in the Canadian post-2018 rollout see: https://www.statcan.gc.ca/.../9129-canadas-cannabis...), the harms attributed to "the drug" have moved with the market change, not independently of it. That is evidence the harm was substantially a market artefact. 2. The referendum as a case of the same error, applied politically The 2020 cannabis referendum is ordinarily narrated as a settled expression of public will: reform was put to a vote and the vote said no. That narration is itself a diagnostic inversion, for two reasons. First, the result was uneven and thin. The equivalent of Blenheim's electorate voted the measure down, while the equivalent of Canterbury's engagement didnt vote at all with the substance of the question being blunted by circumstances that had nothing to do with the Christchurch High Court's considered judgement on cannabis policy. The Electoral Commission, exercising Crown Law, made sure of that. (the writer is on $100,000 / the 2yrs, Bail, until his late September court date, days before the election.... ) [ context: The Electoral Commission lied by omission to the Justice and Electoral Committee by NOT TELLING THEM they had acted in bad faith pretending 'one of our issues' (their portraying 'you are voting for cannabis' was the same as 'your voting for Cannabis Legalisation and Control. ' ] Treating a narrow, unevenly distributed result as a stable national verdict misattributes electoral noise to settled preference, the same inferential error diagnostic inversion makes when it misattributes market harm to pharmacology. Second, the referendum's legal challenge was dismissed on a procedural security-deposit ground, without a hearing on the merits. A statutory right was extinguished by a procedural default before it could be exercised or tested. The subsequent political use of the result, "the public doesn't want this" treats a procedural artefact as though it were a substantive finding. This is the referendum's own diagnostic inversion: process failure relabelled as public verdict. Six years have elapsed on the strength of that relabelling. The cost of that elapsed time is not abstract. It is measured in the continued operation of the prohibition-market harms described in Section 1, harms that a corrected diagnosis would have begun addressing in 2020. 3. RSR 2008 as the corrected diagnosis, not a new argument The Misuse of Drugs (Restricted Substances) Regulations 2008 already exists in New Zealand law as a domestic regulatory counterfactual. Its relevance here is structural rather than rhetorical: it demonstrates that the "how" objection routinely raised against reform, that regulation is administratively untested, does not hold in the New Zealand context, because a workable regulatory instrument already exists. Voting FOR a platform grounded in RSR 2008 is not a request to relitigate 2020's binary conclusion; it is a request to apply an available, evidenced instrument to a diagnosis that has already been corrected in the analysis above. 4. Class D as interim correction Pending any legislative platform built on RSR 2008, Class D reclassification offers an interim mechanism for beginning to correct the misdiagnosis without waiting on a further electoral cycle. The relevant metrics are regional and immediate: Avoided enforcement expenditure, and health system relief, redirected as fiscal dividend, order of magnitude in the billions at a national level, with Canterbury a material beneficiary given its enforcement and health-system exposure. Regulated employment displacing illicit-market activity, an estimated four figures of local jobs across cultivation, testing, retail, and compliance functions, following the pattern already observed in comparable regulated markets since 2018. 5. Conclusion "Not up for discussion" functions, on this analysis, as a claim that the diagnosis is closed. The evidence above suggests the diagnosis was wrong at the point it was closed, and has not been reopened since. MildGreens will continue to advance this analysis in the lead-up to the 7 November 2026 general election, on the basis that a policy built on a corrected diagnosis is not a repeat of an old argument but a first attempt at the right one. Prepared by: Blair Anderson MildGreens Initiative Blog: Blair's Brain on Cannabis. Media Inquiries. cell: 021823647 About MildGreens: MildGreens is a New Zealand cannabis and drug policy reform initiative drawing on the Misuse of Drugs (Restricted Substances) Regulations 2008 and the work of Educators for Sensible Drug Policy (http://EFSDP.org). ENDS

Twenty Stakeholders in Prohibition... who don't want you to read this!

2026-07-29T09:20:47.670+12:00

Fwd: Police Mendacity

2026-07-29T09:13:57.569+12:00

Blair Anderson

Social Ecologist 'at large'
http://blairformayor.blogspot.com

http://facebook.com/mildgreens
http://mildgreens.blogspot.com
http://efsdp.org

Christchurch, New Zealand
nz cell 021 823647

---------- Forwarded message ---------
From: Blair Anderson <mildgreens@gmail.com>
Date: Wed, 22 Jul 2026, 8:56 am
Subject: Police Mendacity
To: Blair Anderson <mildgreens@gmail.com>

If we examine the Police statement through the lens of mendacity — not necessarily as provable lying, but as strategic distortion, omission, framing, insinuation, or half-truth — the release becomes less a neutral report of enforcement activity and more a piece of reputational management.

A careful reading shows several places where Police language appears designed to imply more than it proves.

1. “Multiple breaches of the licence” — vague but prejudicial

Police say they found “multiple breaches of the licence,” but the statement does not specify:

what type of medicinal cannabis licence the person held;
what conditions applied to that licence;
which conditions were allegedly breached;
whether the breaches were technical, administrative, commercial, or criminal;
whether the Medicinal Cannabis Agency had already confirmed a breach.

That vagueness matters. “Multiple breaches” sounds serious, but without particulars it functions as a conclusory smear. The reader is invited to accept that the licence holder was abusing the system, even though the specific licence terms are not explained.

From a mendacity perspective, this is not necessarily a direct lie. It is more subtle: the withholding of context that would allow the public to judge the seriousness of the alleged conduct.

2. “Evidence of cannabis and paraphernalia” — framed as suspicious despite the licence context

Police say they found “evidence of cannabis and paraphernalia” at one property.

But because the person is described as a medicinal cannabis licence holder, the mere presence of cannabis-related material is not automatically incriminating. The key issue would be whether the cannabis or equipment was:

outside the licence conditions;
possessed in unlawful quantities;
intended for unauthorised supply;
kept at an unauthorised location;
unrelated to the licensed medicinal activity.

The release does not explain that evidential bridge. It simply pairs “licence holder” with “cannabis and paraphernalia” and lets suspicion do the work.

This is a classic rhetorical move: state a neutral or ambiguous fact in a context that makes it sound damning.

3. “Allegedly believed to be for personal use” — internally awkward

The sentence says:

“Police found evidence of cannabis and paraphernalia at one of the properties allegedly believed to be for personal use.”

This is strange wording.

If the cannabis was “for personal use,” that usually points away from commercial supply. Yet the person has also been charged with possession of cannabis for supply. Police then add language about “personal use and profit.”

So the release appears to run two narratives at once:

the person was using cannabis personally outside the licence; and
the person was exploiting the system for supply/profit.

Those may both be possible, but the statement does not clearly distinguish them. Instead, it blends them into a general impression of wrongdoing.

Through the mendacity lens, this is category-blurring: personal use, supply, profit, licence breach, and exploitation of vulnerable patients are all rhetorically bundled together, even though they are legally and morally distinct.

4. “Hide behind it” — moral accusation before trial

Police say:

“The medicinal cannabis licensing system exists to support patients... not for someone to allegedly hide behind it for their own personal use and profit.”

This is one of the most loaded lines.

“Hide behind it” implies conscious deception. “Profit” implies commercial exploitation. “Vulnerable people” implies predation. But at this stage the person has merely been charged, not convicted.

Police use “allegedly,” but the moral framing remains powerful. The accused is not simply said to have potentially breached licence conditions. He is portrayed as someone abusing a patient-care system for selfish reasons.

That is arguably prejudicial storytelling rather than neutral public information.

5. “Profit” is asserted rhetorically, but the charges listed do not prove profit

The person is charged with:

possession of cannabis for supply; and
possession of cannabis.

Possession for supply does not necessarily prove actual sale, actual profit, actual victims, or exploitation of patients. It alleges an intent or purpose related to supply.

Yet the statement uses the word profit, which goes beyond the listed charges unless Police have evidence not disclosed in the release.

That may be true in their investigation, but the public statement does not show it. So the word “profit” functions as an aggravating insinuation.

From a mendacity perspective: the release may be converting an allegation of supply into a public impression of corrupt profiteering.

6. “Vulnerable people” — emotional laundering

Police say they will hold to account those who:

“undermine any systems designed to help vulnerable people.”

This is rhetorically effective because it casts Police as protectors of patients and the accused as someone undermining vulnerable people’s access to medicine.

But the statement does not say:

any patients were harmed;
any medicinal cannabis patients were deprived of treatment;
any vulnerable people were exploited;
any licensed medicinal products were diverted;
any fake prescriptions or patient records were involved.

So “vulnerable people” may be less an evidential claim than an emotional device. It morally intensifies the alleged offending without giving concrete facts.

That is not necessarily false, but it is sentimental framing: using the social purpose of the medicinal cannabis regime to make the accused’s alleged conduct appear more sinister.

7. “Police remain committed…” — institutional virtue signalling

The release closes with:

“Police remain committed to ensuring New Zealand's medicinal cannabis regulatory framework operates lawfully and with integrity.”

This positions Police as guardians of regulatory integrity. But medicinal cannabis licensing is primarily overseen by the Medicinal Cannabis Agency, which Police only later say they have referred the matter to.

There is a subtle institutional power move here. Police present themselves not merely as enforcing criminal law, but as defending the integrity of the medicinal cannabis framework itself.

That may be partly true, but it also helps justify aggressive enforcement optics. It makes the operation appear less like a drug bust and more like protection of a health system.

Through the lens of mendacity, this can be seen as mission inflation: expanding the moral meaning of the police action beyond the specific allegations.

8. The statement protects Police uncertainty while projecting certainty

The release repeatedly uses softeners:

“allegedly”
“appears to be”
“potential offending”
“continuing to assess information”
“further charges or arrests aren’t ruled out”

These phrases preserve legal caution. But the overall message is much stronger: the person abused the licence, hid behind the medicinal cannabis system, used it for personal use and profit, and undermined protections for vulnerable people.

So there is a tension between legal hedging and moral certainty.

This is a common form of official mendacity: the institution avoids making directly actionable false claims, while arranging the language so the public draws a harsher conclusion.

9. What is omitted may be as important as what is said

The statement omits key facts that would allow a fair assessment:

quantity of cannabis allegedly found;
whether it was plant material, product, medicine, or cultivation material;
whether the licence authorised possession or cultivation at any searched address;
whether the person had a prescription;
whether the “paraphernalia” was ordinary consumption equipment or commercial equipment;
whether any money, sales records, messages, packaging, scales, or customer lists were found;
what “multiple breaches” actually means;
whether the Medicinal Cannabis Agency had determined any regulatory breach before Police publicised the case.

These omissions are not accidental in effect. They allow Police to preserve investigative secrecy while still obtaining reputational advantage.

The public gets the accusation, but not the evidential detail.

10. The core mendacity: conflating legality, morality, and guilt

The strongest mendacity critique is this:

Police present the matter as if a licence holder was caught corruptly abusing a compassionate medicinal cannabis system for selfish gain. But the concrete public facts only establish that:

search warrants were executed;
cannabis-related evidence was found;
Police believe licence conditions may have been breached;
one man has been charged;
the matter is ongoing;
the Medicinal Cannabis Agency has been notified.

Everything beyond that — “hide behind it,” “profit,” “vulnerable people,” “integrity” — is framing.

The release therefore moves from allegation to moral narrative faster than the evidence publicly disclosed permits.

A more honest version would have said something like:

Police executed search warrants at several Christchurch addresses as part of an investigation involving a medicinal cannabis licence holder. Cannabis and related items were located. Police allege the items were possessed outside the terms of the licence and in breach of the Misuse of Drugs Act. A 40-year-old Christchurch man has been charged with possession of cannabis and possession of cannabis for supply. The charges remain before the court. Police have referred the matter to the Medicinal Cannabis Agency for assessment of any regulatory issues.

That version would inform the public without implying exploitation, profiteering, or bad faith before trial.

Bottom line

Through the lens of mendacity, the Police statement is not necessarily a blatant lie. It is more plausibly an example of official narrative-shaping:

vague allegations are made to sound conclusive;
regulatory breach is fused with criminal offending;
personal use is blended with supply and profit;
the accused is morally framed as exploiting vulnerable patients;
institutional virtue is foregrounded;
evidential specifics are withheld.

The mendacity lies less in any single sentence and more in the architecture of implication. Police say just enough to construct a damning public story, while saying too little for that story to be properly tested.

Blair Anderson

Social Ecologist 'at large'
http://blairformayor.blogspot.com

http://facebook.com/mildgreens
http://mildgreens.blogspot.com
http://efsdp.org

Christchurch, New Zealand
nz cell 021 823647

Canada’s cannabis industry contributes more than $76 billion to Canada’s GDP, generates nearly 100,000 jobs annually

2026-07-29T09:13:42.378+12:00

Sharing this StratCann article with you.

UNODC/World Drug report Critique.

2026-07-29T09:13:38.709+12:00

Analysis

The UNODC/World Drug report contains a clear, albeit implicit, ideological divide. The majority of statements reaffirm a commitment to the existing UN drug control conventions, which are prohibition-based. However, a significant minority of statements, alongside data points within the UNODC presentation itself, provide direct and indirect support for reforms that move beyond a purely punitive, prohibition-centric model.

Content supporting reform falls into several key categories:

Critique of Supply-Side Focus & Emphasis on "Shared Responsibility":
- Colombia delivers the most direct critique of the current system. It argues that the focus remains on supply and countries of origin, while "the efforts and the costs stay at the source," despite demand growing in consumer markets. It calls for "shared responsibility" to be "real or is just a convenient fiction," highlighting that consumer countries host money laundering and demand, not just drug production. It questions measuring success by "hectares eradicated" rather than reduced violence, human suffering, and environmental damage.
- Mexico similarly notes that no country is solely a producer, consumer, or transit state and stresses the need for a health-focused approach, cautioning against "plac[ing] all the blame on the users because that increases criminalization and stigmatization."
Pragmatic Public Health and Harm Reduction Approach:
- Switzerland makes the most explicit statement for reform, asserting, "punishing people who use drugs does not work. Drug dependence is a health condition." It champions its four-pillar policy, including supervised consumption rooms, drug checking, and opioid agonist therapy, stating they "do not encourage substance abuse. They reduce overdoses, offer a compassionate bridge to healthcare, and contribute to reducing acquisitive crimes."
- Uruguay interprets the report’s finding that adverse outcomes are avoided with access to health/social services as confirming its conviction: "public security and public health are not opposing objectives but complementary ones, and responses based solely on repression do not yield lasting results."
- Ghana emphasizes that "as long as treatment is not available, demand will be met by supply," calling for investment in demand reduction infrastructure.
- Brazil, Malta, and the EU statement all stress people-centered, human rights-based approaches that include harm reduction as an essential part of the response.
Support for Alternatives to Punishment and Opposition to the Death Penalty:
- CANZ (Australia, Canada, New Zealand) explicitly notes that "83% of reporting countries have established alternatives to conviction or punishment for drug use offences," framing this as a "growing recognition of the value of proportionate, reviewable, and health-focused responses."
- Multiple delegations (EU, CANZ, Switzerland, Malta, Brazil) strongly and unequivocally oppose the death penalty for drug-related offences, calling for its universal abolition or a moratorium, which challenges a core punitive tool of prohibitionist regimes.
- Colombia offers a concrete example, highlighting its public utility law where "women heads of household have replaced prisons for minor drug offences with community service."
Data-Driven Insights Challenging Prohibition Narratives:
- Chloé Carpentier (UNODC) states the association between drug use and crime/violence "is not deterministic," and depends on factors like poverty, homelessness, and stigma. This directly undermines a simplistic prohibitionist argument that drug use inherently causes crime.
- She also notes a decrease in adolescent cannabis use in some high-income countries, potentially linked to increased risk perception, a fact that can counter narratives that legalization or regulation inevitably increases youth use.
- The stark contrast between the record-high cocaine supply and the call for demand reduction implicitly questions the effectiveness of supply-side interdiction as a standalone strategy.
Call for Systemic Review and New Metrics:
- Colombia and Burkina Faso specifically reference the CND expert panel reviewing the international drug control system's implementation. Colombia states this is a "timely opportunity to review... how we define and measure success, so that our policies are guided by human rights, evidence, effectiveness... rather than by outdated assumptions."
- Uruguay and the Vienna NGO Committee on Drugs (VNGOC) call for the inclusion of human rights and civil society voices, respectively, in policy discussions, challenging the state-centric, enforcement-led status quo.

Summary Brief: Support for Drug Policy Law Reform Beyond Prohibition (CND Special Event, June 26, 2026)

Subject: Analysis of content supporting drug policy reform at the CND event commemorating the International Day against Drug Abuse and launching the 2026 World Drug Report.

1. The Core Critique: The Imbalance of the Prohibitionist Model
A powerful argument was made that the current system places a disproportionate burden on producer and transit countries while consumer markets evade responsibility. Colombia highlighted this failure of "common and shared responsibility," noting that the demand, money laundering, and financial systems that fuel the trade are hosted by nations that focus enforcement pressure on supply reduction abroad. This structural critique calls for a fundamental rebalancing of the global drug control regime.

2. The Paradigm Shift: From Punishment to Public Health
Several states argued that drug dependence is a health condition, not a moral failing requiring criminal punishment. Switzerland explicitly stated that "punishing people who use drugs does not work" and detailed how harm reduction services (supervised consumption, drug checking) improve safety and health. Uruguay and Ghana echoed this, asserting that lasting solutions require complementing law enforcement with robust, accessible public health, treatment, and social services. The statement from CANZ highlighting the widespread use of alternatives to conviction for drug offences reinforces a global trend away from punitive responses.

3. Rejecting the Extremes of Prohibition
A broad consensus from reform-minded states emerged against the death penalty for drug offences, with the EU, CANZ, Switzerland, Brazil, and Malta calling for its abolition. This stance directly challenges the most extreme and irreversible punitive measure under prohibitionist policies. Colombia provided a tangible alternative, replacing prison with community service for minor offences.

4. Evidence from the 2026 World Drug Report
The UNODC’s own data provides levers for reform. The finding that the link between drug use and crime is "not deterministic" and depends on social determinants weakens a core assumption of prohibition. The reported decrease in youth cannabis use in some regions despite policy changes elsewhere provides a data point for discussions on regulatory models not inevitably increasing prevalence.

Conclusion:
The event revealed a growing and assertive bloc of nations arguing that a purely prohibitionist model is unbalanced, ineffective, and unjust. Their calls for reform focus on pivoting from punitive, supply-centric enforcement to a public health and human rights framework, demanding genuine shared responsibility from consumer nations, and replacing criminal sanctions for personal use with health and social support. These positions directly support law reform beyond traditional prohibition.

/Blair Anderson,

Another MildGreen Initiative,

MEDIA INQ: 021823647

CHRISTCHURCH.

Blair Anderson

Social Ecologist 'at large'
http://blairformayor.blogspot.com

http://facebook.com/mildgreens
http://mildgreens.blogspot.com
http://efsdp.org

Christchurch, New Zealand
nz cell 021 823647

European Union Drugs Agency "Whack-a-Mole"; Prohibition Exporting Itself

2026-07-10T11:29:36.666+12:00

The EUDA's New "International Cooperation Framework" Is Just Prohibition Exporting Itself

Blair's Brain on Cannabis — MildGreens

The European Union Drugs Agency (EUDA) has unveiled its new International Cooperation Framework (ICF), pitched as a modernised response to a changing global drug landscape. Read the announcement closely, though, and what's being modernised isn't the thinking, it's the reach. The ICF takes the same supply-reduction logic that already dominates the EU's 2021–2025 Drugs Strategy and extends it outward, dressed in the language of partnership and human rights.

Here's the paragraph doing the work:

Drugs are a transnational phenomenon, affecting communities worldwide and posing challenges to public health and security. Illegal drug flows are increasingly complex, with drugs and key chemical precursors being manufactured and transported across regions, often by transnational criminal organisations. Ongoing wars and conflicts have also had repercussions on drug use and trafficking, including in EU neighbouring countries. The ICF was designed to respond to these realities, drawing on the EMCDDA's history of international cooperation.

Every sentence here is factually defensible. None of it withstands scrutiny as an argument for what it's used to justify.

1. "Drugs are a transnational phenomenon" — yes, and so is every commodity humans have ever wanted

Cannabis, opium, coca and psychoactive fungi have moved across borders and cultures for millennia — as medicines, trade goods and sacraments, long before the 1961 Single Convention existed. What's actually transnational isn't the substance. It's the enforcement regime built around it, and the black-market logistics that regime inevitably produces. By naming "drugs" as the phenomenon of concern rather than "prohibition" as the policy choice generating the disorder, the EUDA frames the object as the compound, not the architecture — the same sleight of hand MildGreens has already flagged in the EUDA's 2026 European Drug Report.

2. "Increasingly complex... transnational criminal organisations" — the enforcement paradigm citing its own failure as proof it needs more resources

This is the tell. Drug market complexity, scale and criminal sophistication aren't facts arriving from outside the system; they are the predictable output of decades of supply-side suppression pushing production and distribution toward the actors best equipped to absorb enforcement risk: violent, well-capitalised, vertically integrated organised crime. Criminalise a market and it doesn't shrink. It professionalises. The EUDA cites this professionalisation as the reason to internationalise its enforcement toolkit, the drug-policy equivalent of raising the dose because the fever went up.

3. Precursor chasing: the problem RSR 2008 solved in 2008

The mention of chemical precursors "manufactured and transported across regions" implicitly endorses precursor interdiction as a security good — an unwinnable, permanent game of chemical whack-a-mole. New Zealand's Misuse of Drugs (Restricted Substances) Regulations 2008 already demonstrated the alternative: a regulated, quality-controlled, risk-tiered domestic supply chain removes the incentive for illicit precursor diversion, because the licit route out-competes it on safety and reliability. RSR 2008 isn't a novel proposal answering the EUDA's 2026 framing. It's an eighteen-year-old answer to a problem the EUDA is still describing as though it were new.

4. Conflict and displacement: real evidence, marshalled for the wrong conclusion

Wars reshaping trafficking routes and drug-use patterns in conflict-affected regions is a genuine phenomenon. But note what this fact is used to justify: expanded security cooperation, not expanded treatment and harm-reduction capacity. The same evidence, trauma, displacement, and disrupted health systems argue at least as strongly for a biopsychosocial, treatment-first response as for an interdiction-first one. The EUDA reaches for enforcement by institutional reflex, not because the evidence points there.

5. Institutional lineage is not an evidentiary claim

The ICF is legitimised by "drawing on the EMCDDA's history of international cooperation" — continuity, not outcomes. Nowhere does the announcement ask whether that history actually reduced the harms it targeted, or how a cooperation model benchmarked against alcohol as the comparative baseline — per the Nutt et al. comparative harm framework, and Andy Towers' Massey University data on hazardous drinking among New Zealanders over 50, might look entirely different in design and priority.

The throughline

Every sentence in the ICF's founding paragraph describes something real: transnational flows, precursor diversion, conflict-linked trafficking, criminal sophistication, and reaches, without argument, for the same conclusion: more enforcement cooperation, exported further. None of these five observations logically compels that answer. Each is at least as well explained, and in most cases better explained, by the market-structure-harm model MildGreens has built against the alcohol comparator: harms generated by how a substance is regulated, not by what the substance intrinsically is.

The paragraph isn't dishonest. It's circular. It uses the visible symptoms of prohibition as the proof that prohibition's toolkit needs internationalising now with a name (ICF) and a budget line to match.

MildGreens Initiative — evidence-based cannabis and drug law reform for Aotearoa New Zealand

Blair Anderson http://mildgreens.blogspot.com

From Unfinished Business to Ready-Made Answer

2026-07-09T10:01:46.933+12:00

From Unfinished Business to Ready-Made Answer: Tracing the 2003 Health Select Committee Inquiry to the MildGreens RSR 2008 Revival.

A MildGreens Initiative analytical document

Introduction
In 2003, the New Zealand Parliament's Health Select Committee completed an inquiry into the public health strategies related to cannabis use and the most appropriate legal status, and delivered a set of recommendations to the coalition government. Those recommendations were substantially about one thing: the government needed a more credible, more evidence-based, more health-oriented relationship with cannabis policy than the Misuse of Drugs Act 1975 provided.

Twenty-plus years on, the evidentiary record has done everything the Committee could have asked of it. It has confirmed, repeatedly and specifically for New Zealand, that the harms the Committee was worried about are downstream of prohibition's market structure rather than the substance itself. What has not happened is the policy response.

This MildGreen introspective traces that gap; from the 2003 recommendations, through the accumulated confirming evidence of the two decades since, to the case that RSR 2008 is not a new proposal requiring fresh justification, but the overdue fulfilment of work Parliament itself asked for in 2003 and never completed.

Part I: What the 2003 Committee Actually Asked For

The Health Select Committee's Inquiry into the Public Health Strategies Related to Cannabis Use and the Most Appropriate Legal Status reported back in 2003, following on from an earlier 1998 inquiry into the mental health effects of cannabis. Its first recommendation was that the government accept a leading role in promoting the message that young people (<20) should not use cannabis, unsurprisingly conventional, health-promotion-style recommendation. But the recommendations that matter more for present purposes were structural: A demand for more credible information and a recognition that blanket prohibition was an impediment to credible health promotion.

One of the constant calls reflected in the Committee's recommendations, coming from parents and teachers, was for more information on the actual harm that cannabis misuse can cause. The clear implication, reinforced by the government's own response, is that the existing 'just say no' information environment was not considered adequately credible by the people the messaging was meant to reach.

A recommendation that the Expert Advisory Committee on Drugs give early reconsideration to cannabis's legal classification.

This is a significant admission built into the Committee's own report: the statutory body designed to assess drug harm and calibrate legal response had, by the Committee's own account, work left to do that the existing MoDA1975 classification hadn't captured.

A recommendation that the Justice and Electoral Committee separately consider the question of cannabis's legal status, [the Health Committee explicitly declining to make that call itself], while flagging that someone in Parliament needed to:

- Recommendations on medicinal use, gated behind standard medicine-approval pathways (dosage, safety, and efficacy standards administered by Medsafe).
- Support for research on cannabis and road safety, and for testing of suicide referrals for drug and alcohol traces, both framed as evidence-gathering exercises, not settled findings.

The government's formal response, delivered by Associate Health Minister Jim Anderton, accepted the "leading role" recommendation, noted most specific recommendations were already reflected in existing agency work, and, critically, declined to change cannabis's legal status, citing the absence of a public or parliamentary mandate for that change, while confirming the Committee had not itself recommended a change.

Anderton's response also confirmed the coalition agreement with United Future's Peter Dunne (who later replaced Anderton's role, and rejected the RSR2008 regulations for his own Psychoactive Substances Act) had effectively frozen the legal status question for the life of that government.

What resulted, in other words, was a Committee that identified real evidentiary and credibility gaps, paired with a conservative government response that used procedural caution (no mandate for change, drugs can only be scaled up the harms schedule, not down) to defer the substantive question indefinitely. The credibility gap the Committee had specifically addressed in 2003 was never actually closed. It was postponed.

Part II: Two Decades of Confirming Evidence

If the 2003 Committee's recommendations were postponed rather than resolved, the subsequent two decades have functioned as an unplanned, real-world test of exactly the questions it left open.

New Zealand-specific evidence has accumulated on precisely the mechanism MildGreens has been arguing for, enabling that crucial Order in Council, gazetted by Prime Minister Rt Hon. Helen Clark 30 days before the 2008 General Election, creating the RSR 2008 framework: a pivot point in drug policy legislation recognising that prohibition's harms are structural and market-based, not pharmacological.

The "cannabis drought" and the meth substitution finding.

The single most direct piece of New Zealand evidence for this argument is Wilkins, Romeo, Rychert, Prasad and Graydon-Guy's 2018 study in the International Journal of Drug Policy, "Determinants of high availability of methamphetamine, cannabis, LSD and ecstasy in New Zealand: Are drug dealers promoting methamphetamine rather than cannabis?"

The study responded directly to a documented phenomenon: small New Zealand towns reporting very high methamphetamine availability at the same time as a widely reported cannabis shortage (described by stakeholders as a "cannabis drought") beginning around 2015, severe enough that one experienced cultivator was reported to have had to buy cannabis for personal use for the first time in twenty years. This was despite New Zealand having sustained large-scale illicit outdoor cannabis cultivation in isolated rural areas for decades, meaning the shortage was not a production-capacity problem, but a distribution and dealer-incentive problem. (not dissimilar to the prohibition era; Rum is more lucrative than Beer.)

This is New Zealand's own domestic version of the fentanyl/heroin dynamic, and it is arguably cleaner evidence than the American case, because it isolates dealer-level substitution behaviour directly: the same illicit distribution networks, given a choice, shifted toward the more compact, more profitable, more concealable product, away from cannabis and toward methamphetamine, as a rational response to enforcement risk and margin, independent of any change in consumer demand for either substance.

Synthetic cannabinoids: the Iron Law made lethal.

Where the meth/cannabis dealer-substitution finding shows the market-structure effect at the distribution level, the synthetic cannabinoid experience shows it at the product-substitution level.

Synthetic cannabinoids that emerged after cannabis prohibition intensified were markedly more potent than the plant they were displacing, and while cannabis itself was not associated with fatal overdose, synthetic cannabinoids in an uncontrolled market have since been linked to over 70 deaths in New Zealand.

This is the Iron Law of Prohibition operating in its most literally lethal form: enforcement pressure on the plant did not reduce demand, it displaced supply toward a manufactured substitute with a materially worse safety profile, precisely because that substitute was easier to produce, transport, and conceal [than herbal cannabis] than the regulated alternative RSR 2008 would have provided. Coupled with anti-smoking legislation and its perceived risks, this was the perfect storm 'chemical good, combustion bad' in the making.

The 2020 referendum and its procedural aftermath.

The Cannabis Legalisation and Control Bill, put to New Zealanders in the 2020 referendum, was narrowly rejected. Analysis of that result has pointed to specific, addressable concerns, including doubts about whether a legal cannabis industry and retail environment could be adequately controlled, [ 'You are voting for Cannabis' Electoral Commission merchandising of the problem ] rather than a wholesale public rejection of regulation as a concept.

This is significant for the RSR 2008 pitch specifically because RSR 2008's five pages of 'erudite and concise' legislation was designed years before that 140 page referendum 'proposed' bill, clearly RSR while broader in enabling, subject to approval, 'anything safer than alcohol', not actually mentioning cananbis, it was a tighter, more tightly bounded regulatory model than the 2020 proposal meaning the specific control concerns raised against the 2020 Bill are substantially the very concerns RSR 2008's architecture was built to answer.

Medicinal cannabis: a partial, incomplete answer to the 2003 recommendations:

The Misuse of Drugs (Medicinal Cannabis) Amendment Act 2018 and the subsequent Medicinal Cannabis Scheme were, in effect, a twenty-years-later fulfilment of the narrowest part of the 2003 Committee's recommendations, the request that medicinal use be considered through standard efficacy and quality pathways.

But this is instructive by contrast: the medicinal scheme did the one thing RSR 2008 does for the whole of cannabis policy, it introduced minimum quality standards so prescribers and patients could have confidence in product consistency. It proved the regulatory mechanism works.

(The Canadian Cannabis transition's history roughly tracked a similar pathway but opted for and legislated, in effect, the MildGreen solution after confronting the Medpot nexus.)

The Misuse of Drugs (Medicinal Cannabis) Amendment Act 2018 never got extended to the general population that the 2003 Committee was actually worried about, the young people whose parents and teachers wanted more credible information in the first place.

Learnings from the current debate.

The EUDA 2026 report: the same category error, exported
The European Union Drugs Agency's 2026 European Drug Report continues to reproduce the identical structural error the 2003 New Zealand Committee was implicitly grappling with two decades earlier: treatment admissions and seizure volumes are read as danger signals about substances, when they are at least as much a function of enforcement intensity and market size as of pharmacological harm.

The persistence of this error at a supranational level in 2026 is itself evidence that the credibility gap the 2003 Committee identified was never a local New Zealand problem to be solved with better local messaging; it is a structural feature of prohibition-era data architecture generally, and it recurs everywhere prohibition persists.

Part III: Why "Credible Drug Education" Was Never Achievable Without Regulation.

The throughline connecting all of the above evidence to the 2003 Committee's actual language is this: credibility in drug education is not a communications problem; it is a supply-chain visibility problem, and prohibition makes supply-chain visibility structurally impossible.

Consider what the 2003 Committee was actually being asked for by parents and teachers: information on the actual harm cannabis misuse can cause. But under prohibition, "actual harm" is unknowable in any specific, actionable sense, because:

No one administering health messaging has visibility into what is actually circulating. Potency, contamination, and adulteration in an illicit cannabis market are unknowns by design; there is no quality-control mechanism to generate the data health educators would need to speak credibly to current conditions.

The meth-substitution evidence shows the product itself can change without warning or detection. A health curriculum built around cannabis-specific risk messaging has no mechanism for capturing a town-level shift toward methamphetamine promotion by dealers, because that shift is a black-market distribution decision, invisible to any public health surveillance system until harms have already accumulated.

The synthetic cannabinoid deaths show the limiting case. No amount of "credible" messaging about cannabis itself could have prevented deaths from a product that only exists because cannabis was suppressed.

The relevant risk information didn't fail to reach people, it was about the wrong substance entirely, because prohibition manufactured a new one.

Illegality collapses the distinction between "harmful" and "prohibited" in the messaging itself, and young people discount messages that can't or won't separate the two.

This is precisely why the Expert Advisory Committee on Drugs, the body responsible for calibrating classification to actual harm was asked in 2003 to reconsider the classification question early: the Committee itself recognised that classification and harm needed to be reconnected, but that recommendation was never substantively actioned. [ It appears that it never actually addressed its brief at all ]

None of this is a failure of educators, curriculum design, or public messaging discipline. It is what happens when a health-promotion function is asked to operate credibly inside a market it has no regulatory access to.

The 2003 Committee asked for credible information without asking for the one precondition that makes credible information possible: visibility into supply. RSR 2008 supplies exactly that precondition.

Part IV: RSR 2008 as the Answer Already Sitting There.

This is the point the two decades of evidence converge on. RSR 2008 was not designed as an abstract legalisation proposal. It was designed as a regulatory architecture that puts the state inside the cannabis supply chain, licensing, quality control, potency labelling, and controlled points of sale, which is precisely the mechanism that:

- Removes the dealer-level incentive documented in the Wilkins et al. meth-substitution study. A licensed, regulated cannabis market removes the profit-margin logic that made methamphetamine more attractive than cannabis to illicit distributors in the first place. That incentive only exists because cannabis supply is criminalised; regulation dissolves it directly, rather than trying to out-message it.

- Eliminates the market gap synthetic cannabinoids were invented to fill. Once cannabis itself is legally available through a regulated channel, there is no commercial niche for a synthetic substitute to occupy. RSR 2008 doesn't just make cannabis safer — it makes the entire synthetic cannabinoid product category commercially unnecessary.

- Answers the specific control concerns that sank the 2020 referendum, because RSR 2008's regulatory bounds were built years earlier and more conservatively than the Bill that was rejected, meaning the "can this actually be controlled" objection has an existing, more tightly specified answer available.

- Generates the supply-chain visibility that makes "credible drug education" possible for the first time, extending exactly the mechanism the medicinal cannabis scheme proved works (minimum quality standards, prescriber/patient confidence) to the general population the 2003 Committee was actually asked to protect.

- Gives the Expert Advisory Committee on Drugs the reconsideration basis it was asked to develop in 2003, a live, evidence-generating regulated model rather than a hypothetical one, from which actual harm data (not enforcement-intensity data) can finally be drawn.

Put simply: everything the 2003 Committee asked for, and everything twenty years of evidence has since confirmed was missing, is what RSR 2008 was built to provide. It isn't competing with the 2003 recommendations. It's their unimplemented conclusion.

Part V: The Revival Pitch.

For MildGreens' present parliamentary and public communications, this history supports a specific framing choice: RSR 2008 should not be pitched as a new ask, but as the fulfilment of Parliament's own unfinished 2003 business, now supported by twenty years of New Zealand-specific evidence the Committee did not have in front of it.

The pitch has four components:

1. Reframe the ask as institutional continuity, not novelty. Parliament's own Health Select Committee identified the credibility gap in 2003 and asked the Expert Advisory Committee on Drugs to revisit classification. That reconsideration never meaningfully happened. RSR 2008 is the mechanism by which it can, finally.
This is closing a loop Parliament opened, not opening a new one.

2. Lead with the domestic evidence, not the international comparison. The Wilkins et al. meth-substitution finding and the synthetic cannabinoid death toll are New Zealand-specific, peer-reviewed or coronial-grade evidence bases that speak directly to New Zealand towns, New Zealand dealers, and New Zealand deaths. This evidence is harder to dismiss as "someone else's drug policy" than the US fentanyl comparison, and it should anchor the argument before international parallels are introduced.

3. Use the medicinal cannabis scheme as proof of mechanism. The 2018 scheme is a live, government-run demonstration that quality-standard regulation of cannabis works administratively in New Zealand. RSR 2008 is the same mechanism, scaled, not an unprecedented regulatory leap, but an extension of an already-functioning model.

4. Position "credible drug education" as the health promotion frame, not the enforcement frame. The 2003 Committee's own language, "credible" information, requested by parents and teachers gives MildGreens a health-select-committee-sourced mandate to argue that regulation is a precondition for the education outcomes Parliament already said it wanted, rather than an alternative to enforcement that has to win on separate grounds.

Conclusion:

The 2003 Health Select Committee inquiry asked good questions and received a government response that deferred them behind the absence of a political mandate. In the intervening two decades, New Zealand generated its own direct evidence, a documented dealer-level shift toward methamphetamine amid a cannabis shortage, a synthetic cannabinoid death toll running past 70, a narrowly failed but instructively specific referendum, and a working medicinal cannabis scheme that proves regulation is administratively achievable.

None of this evidence was available to the 2003 Committee. All of it validates the direction RSR 2008 had already taken by the time it was formalised in 2008.

The revival pitch is not that MildGreens has a new idea. It is that Parliament already identified the problem, already pointed toward the kind of solution required, and has now had twenty years of confirming evidence delivered to its door with RSR 2008 the only framework on the table that actually answers the brief.

Prepared by Blair Anderson,
Another MildGreen Initiative,
Christchurch, NZ.

media inquiry: 021823647

Blair Anderson http://mildgreens.blogspot.com

Cannabis and the Drug We Drink

2026-07-07T00:18:33.298+12:00

For immediate release — Christchurch, 6 July 2026

New data from the European Union Drugs Agency (EUDA) confirms what MildGreens has argued for over two decades: the harms attributed to cannabis are, overwhelmingly, harms manufactured by prohibition; and New Zealand already drafted the regulatory fix, in 2008.

(Subsequently rejected by United Future's Peter Dunne's coalition agreement.)

The EUDA's European Drug Report 2026, released last month, issued the agency's first-ever European Drug Alert System warning after United States/Mexican cannabis entering European markets was found contaminated with hazardous pesticides and sold at unpredictable, escalating potency.
The same report documents cannabis resin and herbal products increasingly adulterated with potent synthetic cannabinoids; substances substituted into the supply chain precisely because no lawful, inspected chain exists to prevent it.

"Read carefully, EUDA isn't describing a dangerous plant. It's describing a dangerous absence of regulation," says Blair Anderson, Christchurch-based drug policy reform advocate and co-architect of New Zealand's Misuse of Drugs (Restricted Substances) Regulations 2008 (RSR 2008), which Anderson presented to the Canadian Senate in 2009.

"Every failure point EUDA lists contamination, unlabelled potency, and synthetic substitution is a failure of supply chain, not pharmacology. We wrote the fix for this twenty years ago. Canada adopted it, it has now delivered, according to Deloitte's and Statistics Canada, a more than a seventy billion-dollar GDP social dividend."

The RSR 2008 mapping;
The 2008 regulations were built on a pre-market approval model: no restricted substance could reach a retail shelf without prior regulatory sign-off, reversing the default under which unregulated products circulate until proven harmful after the fact. Alongside that gatekeeping function, the regulations mandated product labelling identifying the substance, its strength and its status, controlled packaging, storage and signage requirements, and restrictions on where and how a restricted substance could be sold.

Mapped against this week's EUDA findings, the gaps close:

- Pesticide contamination in trafficked cannabis prevented by a licensed, inspected supply chain with pre-market approval, the precise mechanism the 2008 regulations required before any product could reach the point of sale.

- Unpredictable, unlabelled potency driving emergency department presentations prevented by mandatory product labelling, the same labelling requirement the 2008 regulations imposed on every restricted substance sold at retail.

- Synthetic cannabinoid adulteration of resin and herbal cannabis; a substitution crime that has no economic rationale inside a legal, tested, licensed market; it exists only because the illegal market rewards cutting product to both stretch supply and condense it into an easier-to-hide format.

-Trafficking networks diversifying into drones, speedboats and shipping containers; a distribution problem that a controlled, licensed point-of-sale system, of the kind the 2008 regulations specified, was designed to make commercially irrelevant.

The comparator that keeps proving the point;

The same week, Massey University alcohol researcher Professor Andy Towers confirmed that New Zealanders over 50 top an eight-country hazardous drinking comparison, and that the national drinking guidelines, unrevised since 2011, no longer reflect the evidence, with no safe threshold now recognised for a substance directly linked to seven cancers.

"That's the honest comparison," says Anderson. "Alcohol's harm is in the molecule, and no regulation removes it. Cannabis's harm, on EUDA's own evidence, is overwhelmingly in the black market surrounding it; and that part we know how to fix, because we already drafted how."

MildGreens Initiative calls on the New Zealand Government to:
- Revisit the RSR 2008 pre-market approval and labelling framework as the baseline for a regulated adult cannabis supply model.
- Commission an independent comparative harm assessment placing alcohol and regulated cannabis on the same evidentiary footing used by EUDA and Massey's alcohol research team.
- Treat contamination and adulteration data from unregulated markets as an argument for regulation, not as evidence against it.

Media contact: Blair Anderson, MildGreens Initiative / Educators for Sensible Drug Policy (EFSDP), Christchurch. NZ
021823647
http://mildgreens.blogspot.com

https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/canadian-cannabis-survey-2024-summary.html

https://www.deloitte.com/ca/en/Industries/consumer-products/research/an-industry-makes-its-mark.html

(link to this media release - https://mildgreens.blogspot.com/2026/07/cannabis-and-drug-wedrink.html )

Comments Welcome:

POLICY BRIEF - A framework for deliberating drug policy reform

2026-06-17T11:04:55.832+12:00

(Readers who support this initiative may like to copy it to the Health Select Committee with a personal note of support. )

POLICY BRIEF - A framework for deliberating drug policy reform

Audience: Health Select Committee

Framing Drug Policy Deliberations: Aligning Aotearoa New Zealand's Approach with Health, Human Rights, and the Health and Welfare of Humankind

Executive Summary

This brief, prepared by the MildGreens Initiative, recommends that the Committee frame its deliberations around the founding purpose of the international drug control conventions, "the health and welfare of mankind", rather than a narrow enforcement paradigm. A health- and rights-based frame is consistent with New Zealand's existing legislative trajectory, its Te Tiriti o Waitangi obligations, its international human rights commitments, and the evidence base. We propose five framing principles and a set of guiding questions to structure inquiry.

Why the Frame Matters

How a problem is framed determines which evidence is treated as relevant and which solutions appear legitimate. Framing drugs primarily as a criminal-justice matter narrows options to enforcement metrics (seizures, arrests). Framing them as a health and wellbeing matter opens the full range of public health, social, and economic lever and aligns deliberations with measurable outcomes for people and communities.

New Zealand has already moved in this direction: the 2019 amendment to the Misuse of Drugs Act affirming Police discretion to use a health-based approach, the medicinal cannabis scheme, and the drug-checking legislation, and current deliberations regarding a Samaritan approach for healthier outcomes all signal a shift the Committee can build on coherently.

Five Framing Principles:

1. Health and welfare as the measure of success:
Adopt outcomes-based metrics: reductions in overdose deaths, blood-borne virus transmission, problematic use, and improved access to treatment and pain relief rather than enforcement throughput.

2. Te Tiriti o Waitangi at the centre:
Māori are disproportionately harmed by both drug-related harm and by enforcement. Frame deliberations to honour tino rangatiratanga, partnership, and equity. Seek Māori leadership in design, not just consultation. Recognise the relevance of Māori models of health (e.g. Te Whare Tapa Whā).

3. Human rights and proportionality:
Test every measure against rights commitments: freedom from discrimination, the right to health, and proportionate, non-stigmatising responses. Personal use is best understood as a health matter.

4. Equity and social justice:
Examine the distribution of harm across Māori, Pacific peoples, youth, rural communities, and people experiencing deprivation. Ask who bears the costs of current settings.

5. Evidence and pragmatism over ideology:
Privilege peer-reviewed evidence, evaluation data, and lived/living experience. Treat harm reduction as established public health practice, not a contested concept.

Guiding Questions for Deliberation:

The Committee may structure its inquiry around:

- Does this measure reduce drug-related harm and improve health and welfare?

- Is it consistent with Te Tiriti and does it advance Māori health equity?

- Is it proportionate and rights-consistent?

- Does it reduce or worsen inequities?

- What does the evidence (domestic and international) show about its effects?

- Does it improve access to controlled medicines for pain and palliative care?

- How will outcomes be measured, evaluated, and adjusted?

Aligning with the International Framework:

New Zealand can pursue health-centred reform "within" its treaty obligations. The UN System Common Position (2018) endorses decriminalisation of possession for personal use, and WHO, UNAIDS, OHCHR and UNDP all support a health and rights frame.

The Committee can confidently note that a wellbeing-centred approach is the mainstream international direction, not a departure from it.

Recommendations

1. "Adopt an explicit framing statement" anchoring deliberations in health, wellbeing, equity, Te Tiriti, and human rights.

2. "Embed Māori partnership" in the inquiry's process and analysis.

3. "Use outcomes-based criteria" to assess all options.

4. "Hear from lived/living experience" alongside clinical and enforcement evidence.

5. "Frame personal use as a health matter" while distinguishing it from commercial supply.

6. "Commit to evaluation" any reform should be monitored and evidence-led.

Conclusion:

By framing its work around the health and welfare of people and communities, the Committee places its deliberations on firm legal, ethical, and evidential ground, consistent with both Aotearoa's domestic direction and the original purpose of the international drug control system.

[This brief prepared as Another MildGreen Initiative is intended to assist framing and does not prescribe specific legislative outcomes, which remain matters for the Committee's judgement informed by full evidence and submissions.]

/ Blair Anderson,
cell 021823647
Another MildGreen Initiative,
Christchurch, NZ 8006.
mailto:mildgreens@gmail.com

Cannabis, Cannabinoids & Performance: Rethinking Impaired Driving Science and the Case for Rational Drug Policy Reform

2026-06-16T09:09:56.972+12:00

Apologies, the evil format bug has eaten a nice layout. I am working on it.

--- # THE MILDGREENS INITIATIVE ## Cannabis, Cannabinoids & Performance: Rethinking Impaired Driving Science and the Case for Rational Drug Policy Reform **A Research Position Paper | MildGreens Initiative** *Compiled, Collated & Presented by the MildGreens Initiative Research Desk* *Third Edition — Embedding the Displacement Effect and the Credibility Crisis in Drug Education* *Informed by peer-reviewed literature through 2025–2026* --- > *"The honest scientific conclusion is not that cannabis is 'good' or 'safe' — it's that the binary framework that treats cannabis and alcohol as equivalent intoxicants is neurobiologically illiterate. They act on fundamentally different systems, produce fundamentally different cognitive states, and have fundamentally different relationships to human performance."* --- ## PREFACE: THREE OMISSIONS, ONE BROKEN FRAMEWORK Previous editions of this paper identified two critical structural omissions in the cannabis-impaired driving policy framework: first, the unreliability of per se THC blood thresholds as proxies for actual impairment; and second, the failure to account for the pre-drive decision — the neurobiologically critical moment at which a person chooses whether to get behind the wheel at all. This edition adds a third omission that is, in some respects, the most consequential of the three — because its implications extend not merely to enforcement, but to the entire architecture of public health communication: **The near-total absence, in cannabis-impaired driving policy, of the documented finding that cannabis use typically displaces alcohol consumption — and that this displacement has direct, measurable implications for road safety.** This omission does not occur in isolation. It occurs within a drug education ecosystem that the New Zealand Health Select Committee identified, as early as 1998, as having been fundamentally compromised by prohibition itself — a system in which the legal status of cannabis made it impossible to communicate credible, evidence-grounded information to the people most likely to use it. That diagnosis, made more than a quarter century ago, remains almost entirely unaddressed. Its consequences for road safety are felt every time a public campaign treats cannabis and alcohol as neurobiological equals, ignores the substitution evidence, and thereby forfeits the credibility that honest education requires. The MildGreens Initiative presents this paper as the most complete statement yet of what an evidence-based, neurobiologically literate approach to cannabis, alcohol, and road safety would look like — and what prohibition and its intellectual legacy have cost us. --- ## PART ONE: THE NEUROBIOLOGY OF TWO DIFFERENT INTOXICATIONS ### 1.1 — Alcohol: A System-Wide Depressant That Dismantles the Decision Layer First Alcohol's mechanism of impairment is not limited to motor coordination or reaction time. Its most consequential neurological damage may be something far more upstream: the systematic erosion of the cognitive machinery responsible for deciding whether to drive in the first place. The principle that best describes this is **Alcohol Myopia Theory** — one of the most robustly replicated constructs in cognitive psychology. Alcohol's myopic effects cause intoxicated people to respond almost exclusively to their immediate environment. This neurochemical "nearsightedness" limits their ability to consider the future consequences of their actions and regulate reactive impulses. At the driving decision level, this is not a metaphor — it is a pharmacological mechanism. The drunk person who picks up their car keys is not simply ignoring risk. They are neurologically incapable of fully processing it. Research confirms this mechanism with precision. At lower alcohol concentrations, people tend to overestimate their intoxication; but at higher concentrations — where impairment most matters — they are more likely to *underestimate* it. Underestimates of blood alcohol concentration are associated with decisions to perform risky behaviours such as operating a motor vehicle. And critically, prior to consuming alcohol, those who will eventually reach higher BAC levels report significantly greater confidence in their ability to drive over the legal limit — with those in the highest condition group reporting greater perceived driving capabilities even as their actual BAC climbs. The consequence is a deeply dangerous feedback loop: those most impaired by alcohol are most neurologically prevented from recognising their impairment, and most pharmacologically encouraged to overestimate their driving capability. A significant proportion of people across the globe acknowledge the possibility of driving over the legal BAC limit — and the reason is not defiance, but that those with higher alcohol intoxication may be more likely to falsely perceive themselves as under the legal BAC limit. Alcohol, in short, not only impairs the drive. It systematically corrupts the decision about whether to drive. ### 1.2 — Cannabis: A Targeted Modulatory System With a Different Relationship to Self-Awareness Cannabis operates through an entirely different neurobiological architecture. Rather than flooding inhibitory systems indiscriminately, THC interacts with the endocannabinoid system — a pre-existing regulatory network in the human brain with CB1 and CB2 receptors functioning as inhibitory modulators of classical neurotransmitters. Unlike alcohol's assault on executive function and self-appraisal, cannabis produces a qualitatively different relationship to self-awareness. Most cannabis-impaired drivers tend to be aware of their diminished capacities and drive more cautiously. Cannabis impairment may lead to anxiety and paranoia, which may make a driver more cautious and want to drive more slowly. While anxiety and paranoia are not therapeutically desirable states, their behavioural consequence in the driving context — *caution* — is the precise opposite of the overconfidence that alcohol myopia generates. These are not equivalent neurological signatures. They are, in terms of risk architecture, near-opposite ones. This retained metacognitive access — the cannabis user's capacity to perceive and respond to their own impairment — is the neurobiological feature that the alcohol-cannabis equivalence framework most conspicuously erases. It has profound implications not only for the pre-drive decision, but for what kind of public education can actually work — and why prohibition has systematically prevented that education from being delivered credibly. --- ## PART TWO: THE PRE-DRIVE DECISION — THE FIRST STRUCTURAL OMISSION ### 2.1 — What Policy Measures and What It Does Not Current drug-impaired driving policy operates almost exclusively in the post-ignition space. It measures impairment after the car is moving. It tests blood after a crash or a traffic stop. It sets thresholds for substances already in the bloodstream. What it does not measure, does not threshold, and does not address in any legislative framework is the pre-drive decision — the neurobiological moment at which a person evaluates their own state and chooses, or declines, to drive. This omission is the most consequential divergence between alcohol and cannabis risk — and it has been almost entirely invisible in the policy literature. ### 2.2 — The Asymmetry in Who Decides Not to Drive The available data on pre-drive decision-making reveals a pattern that equivalence frameworks cannot account for. Impairment from alcohol often leads to overconfidence, impaired judgment and increased risk-taking behaviour — evidenced by speeding, weaving through traffic and ignoring traffic signals. The cannabis profile is different: experimental studies suggest that drivers exhibit some awareness that cannabis impairs driving ability, as they compensate by slowing down. Eighty-nine per cent of young drivers surveyed said they would not get behind the wheel after consuming alcohol, while only 66 per cent said the same after consuming cannabis. This finding is routinely cited as evidence that cannabis users are more reckless than alcohol users. But it carries a profoundly different reading: the overwhelming majority of people who consume alcohol express lower behavioural commitment to *not* driving — proportionally more than cannabis users in the same sample. The structural asymmetry is clear: alcohol pharmacologically ensures that the decision not to drive is made badly. Cannabis, in many circumstances, does not. ### 2.3 — The Compensation Phenomenon, Reconsidered Public health campaigns aimed at cannabis-impaired driving prevention frequently rely on perceived feeling of intoxication — the "If you feel different, you drive different" framework. This messaging works, to the extent it works at all, *precisely because cannabis users retain the metacognitive capacity to feel impaired and act on that feeling*. The same campaign aimed at alcohol users fails because alcohol has already dismantled that metacognitive capacity. Policy that treats cannabis messaging and alcohol messaging as interchangeable — as though both substances permit the same relationship between perceived impairment and behavioural response — is not just scientifically incoherent. It is counterproductively designed. ### 2.4 — The Combined Use Problem: When Cannabis Loses Its Protective Properties The special danger of cannabis-alcohol combination use is directly illuminated by the pre-drive decision framework. Combining alcohol and cannabis significantly amplifies the impairing effects of both substances, and research shows that users are more likely to drive after using both substances than after using marijuana alone. This finding is theoretically central. The reason combined use increases the likelihood of driving is precisely that alcohol eliminates the anxiety, heightened self-monitoring, and cautious disposition that cannabis alone may produce. The alcohol-cannabis combination is more dangerous not simply because of additive biochemical impairment, but because alcohol specifically dismantles the psychological and metacognitive barriers that cannabis may have erected against the decision to drive at all. A policy framework that treats cannabis and alcohol as equivalent has no mechanism to explain this interaction — because it has no mechanism to account for cannabis's relationship to the pre-drive decision. --- ## PART THREE: THE DISPLACEMENT EFFECT — THE SECOND STRUCTURAL OMISSION ### 3.1 — The Finding That Policy Has Not Integrated The research literature on cannabis and alcohol contains a body of evidence that has been, at best, acknowledged at the margins of drug policy and, at worst, actively ignored. It is this: **cannabis use, in most observational and many experimental settings, functions as a substitute for alcohol consumption — and this substitution has measurable implications for road safety.** The overall evidence regarding complementarity and substitution of cannabis and alcohol is mixed, but researchers have identified stronger support for substitution than complementarity, though evidence indicates different effects in different populations and across different study designs. Other observational studies have reported reductions in alcohol consumption when cannabis was used before alcohol. The effects of cannabis on alcohol craving and consumption during simultaneous use may be mediated in part by subjective effects — such as relaxation versus stimulation — with simultaneous use predicting discontinuation of drinking via increased relaxation and decreased alcohol craving. Together, these findings suggest the potential for cannabis to act as a substitute for alcohol. In a dispensary-based survey of 404 medical cannabis patients in British Columbia, over 41% stated that they use cannabis as a substitute for alcohol. This is not an anecdotal finding from the margins of cannabis advocacy literature. It is a replicated pattern across laboratory, survey, and ecological momentary assessment studies. And it carries implications for road safety that the alcohol-cannabis equivalence framework is structurally incapable of processing. ### 3.2 — The Road Safety Implications of Substitution If a meaningful proportion of cannabis users are consuming cannabis *instead of* alcohol — not in addition to it — then the relevant policy question is not simply "does cannabis impair driving?" It is: "compared to what?" The answer, in many real-world usage scenarios, is not "compared to sobriety." It is "compared to alcohol." If the two drugs are substitutes, then increased accessibility to marijuana may reduce drunk driving, thereby decreasing fatalities. Medical marijuana laws have been associated with 8%–11% reductions in traffic fatality rates compared with before the laws were enacted. Within a Canadian managed alcohol programme, the final model found evidence of a substitution effect — participants who used more cannabis on average also consumed less alcohol overall. Concerns about the long-term health risks associated with high levels of alcohol use have driven interest in cannabis substitution as an additional harm reduction strategy, and given the lower harm profile of cannabis, its integration offers a promising avenue for further reducing alcohol-related harms. In Colorado, legalisation of recreational cannabis was associated with a 13% decrease in purchasing for all alcohol products combined when compared to all non-policy states. In Washington between 2014 and 2016, no significant changes were seen in self-reported alcohol consumption; however, self-reported alcohol-related harms decreased post-legalisation. The pattern is not uniform or universal — results reveal compelling evidence for both substitution and complementary effects, with nuanced yet significant distinctions across different populations, including patterns and context of co-use, timing and order of use, cannabinoid formulation, pharmacokinetic interactions, and user characteristics. But the *direction* of the dominant finding, across the preponderance of evidence, is toward substitution — and this direction has road safety consequences that policy has not begun to model honestly. ### 3.3 — The Complementarity Exception and What It Actually Tells Us Responsible analysis requires acknowledgment that some populations show complementary rather than substitution effects — that is, cannabis use and alcohol use increase together. A study of NSDUH data comparing states with legalised medical cannabis to states without found that binge drinking among adults of legal drinking age increased 6–9% after medical cannabis legalisation. These findings are real and they must inform policy. But the existence of a complementary effect in some populations does not neutralise the substitution effect in others — it *specifies* where targeted intervention is most needed. A policy framework built on honest data would ask: what conditions produce substitution versus complementarity? What individual and contextual factors predict whether a cannabis user is drinking less or drinking more? These are answerable questions — but they require a policy environment that allows the questions to be asked, and a drug education system credible enough to influence the answers. The MildGreens Initiative submits that prohibition has made both impossible — and that this is not incidental to the evidence gap, but the central cause of it. --- ## PART FOUR: THE CREDIBILITY CATASTROPHE — PROHIBITION AS AN OBSTACLE TO HONEST EDUCATION ### 4.1 — The New Zealand Health Select Committee: A Warning Issued in 1998 and Still Unheeded In 1998, New Zealand's Health Select Committee conducted a landmark inquiry into the mental health effects of cannabis — one of the most thorough parliamentary examinations of cannabis policy in the Southern Hemisphere at that time. Among its most consequential findings was a structural observation that cut to the heart of drug education itself. The Committee recognised that, despite the efforts of law enforcement and education agencies, large numbers of New Zealanders use cannabis — noting that 43 percent of the sample of one recent study admitted to having used the drug. The Committee's analysis pointed to a fundamental tension: that prohibition, by requiring drug education to begin from the premise that cannabis is uniformly dangerous and categorically prohibited, forced educators into a position of stating claims that users' direct experience could contradict. When official education says that cannabis and alcohol are equivalent risks, and users' lived experience tells them otherwise, the result is not compliance — it is a collapse of the entire credibility relationship between young people and the institutions trying to keep them safe. The New Zealand National Drug Policy itself emphasised credible messages about drug-related harm — yet the policy framework simultaneously prevented those messages from being grounded in the full weight of the evidence. This contradiction is not a minor administrative inconsistency. It is the structural failure at the root of a generation of ineffective drug education. ### 4.2 — Credibility as a Public Health Asset — and Prohibition as Its Destroyer The Select Committee's insight deserves to be stated with the directness it warrants: prohibition does not merely fail to prevent cannabis use. It actively undermines the credibility of the educational institutions tasked with communicating about it. Some individuals in society will choose to use drugs regardless of their legal status, and prohibition of drugs can cause more harm than it prevents. Drug policy should have a primary focus on improving public health instead of trying to punish users. When drug education is required, by the terms of prohibition, to characterise cannabis as equivalent to heroin in its legal scheduling and equivalent to alcohol in its impairment profile, it makes claims that are: - **Neurobiologically inaccurate** — as the comparative pharmacology reviewed throughout this paper demonstrates. - **Experientially falsifiable** — as any regular cannabis user, or anyone who has observed the behavioural difference between a drunk and a stoned individual, can attest. - **Strategically counterproductive** — because the moment a young person identifies one exaggeration or inaccuracy in official drug education, the entire edifice of that education loses its persuasive authority. Public education is going to be key — and in Canada, aggressive public education was a central factor in dramatically reducing tobacco use rates in younger cohorts. The lesson from tobacco is that honest, evidence-grounded communication, not prohibition-driven exaggeration, produces durable behavioural change. A drug education system anchored to accurate neurobiological distinctions would be *more* persuasive precisely because it tells the truth about what each substance actually does. ### 4.3 — What Credible Cannabis Education Would Actually Say The New Zealand Committee's implicit challenge was never answered: what would drug education that was grounded in what most people actually experience — rather than worst-case scenarios or exceptional cases — look like in practice? The MildGreens Initiative proposes that credible cannabis education, built on the evidence reviewed in this paper, would make the following honest statements: **It would say:** Cannabis affects your ability to drive. The effects are real, particularly on automated functions and reaction time. You should not drive when acutely impaired. **It would also say:** Cannabis and alcohol are not the same thing. Alcohol makes you more likely to overestimate your driving capability and more likely to decide to drive. Cannabis, in many cases, makes you more likely to underestimate your capability and more cautious in your behaviour. These are different risk profiles that require different responses. **It would say:** If you choose to use cannabis instead of alcohol on a given occasion, the road safety evidence suggests this is, on balance, a lower-risk choice — *particularly if you do not combine the two substances*. The combination of alcohol and cannabis is more dangerous than either alone, and understanding this distinction is more protective than pretending it does not exist. **It would say:** Wait before you drive. The evidence on timing matters. The impairment from acute cannabis use is real in the hours following consumption. It is not the same as testing positive for THC metabolites days later. Knowing the difference protects you. **It would say:** The legal threshold for THC in your jurisdiction may not reflect your actual impairment. You can be legally culpable while functionally unimpaired, and this is a product of inadequate science in the law — not evidence that you should drive. This is education grounded in what most people experience. It does not celebrate cannabis use. It does not endorse impaired driving. It treats the audience as adults capable of responding to evidence — which is the only kind of education that has ever produced durable behavioural change. ### 4.4 — The Worst-Case Scenario Problem The New Zealand Committee's warning about credibility points to a specific failure mode in drug education that has been replicated across jurisdictions for decades: the construction of drug risk messaging around exceptional, worst-case scenarios rather than typical, modal experiences. This failure mode is not accidental. It is a structural consequence of prohibition. When the law treats cannabis as categorically prohibited, drug education must justify that prohibition — and justification requires worst-case framing. The result is a communication strategy built on the least representative examples of cannabis use and its consequences. The problem is not that worst-case scenarios are false. Severe cannabis-induced anxiety, psychosis, or impairment exists in the record and should not be minimised. The problem is that basing the entirety of public health messaging on exceptional cases — while ignoring the typical experience of the majority of users — produces an education system that is structurally dishonest. And a structurally dishonest education system does not protect the public. It forfeits its own authority. Social research is seldom an exact procedure and judgements are frequently made based on available information. The Select Committee considered all material provided and drew conclusions accordingly, noting issues about which information was scarce. The willingness to acknowledge what is not known — to distinguish between what the evidence shows and what it does not — is the foundation of credible communication. It is also precisely what prohibition-era drug education has been structurally prevented from doing. --- ## PART FIVE: THE MEASUREMENT CATASTROPHE — WHY PER SE THC LAWS FAIL ### 5.1 — Blood THC Is Not Blood Alcohol The policy assumption that THC blood concentration can serve as a surrogate for impairment — as BAC does for alcohol — is one of the most scientifically contested ideas in contemporary drug policy. Breathalyser tests work for alcohol in part because they measure impairment directly, compensating for the very metacognitive damage that alcohol inflicts. THC blood limits share none of this logic. Cannabis users' retained metacognitive capacity means that self-assessed impairment is a *more* meaningful data point — not a less meaningful one — than it is for alcohol. The pharmacokinetic evidence reinforces this. THC typically reaches peak concentrations well above 100 ng/mL within minutes of inhalation and then rapidly decreases to between one and four ng/mL within three to four hours — however, heavy users' blood can contain detectable amounts of THC even after extended periods of abstention. A landmark 2025 clinical study made the implications explicit: forty-three percent of regular cannabis users exceeded zero-tolerance statutes at baseline after abstaining for at least 48 hours; 24% had blood THC concentrations at or above the per se cut-off of 2 ng/mL. And crucially, simulated driving performance was not different between those who exceeded per se cutpoints and those below them. ### 5.2 — Per Se Laws: Criminalising Residue, Not Impairment — and Poisoning the Education Well The injustice of per se THC laws is well-documented: they criminalise abstinent users, fail to identify actually impaired drivers, and have no reliable pharmacological basis for the thresholds they impose. Prohibitionists frequently point to studies claiming that fatal crashes involving drivers who recently used marijuana doubled in Washington after legalisation — however, if the state laboratory identified THC in a driver's blood, the authors categorised that as "recent use," even though THC can be present in one's system long after cannabis' effects have worn off. But there is a dimension of this failure that connects directly to the credibility of drug education — and it is the dimension that the New Zealand Select Committee's insight most powerfully illuminates. When law enforcement and public health institutions point to THC detection as evidence of impairment, and when users know from direct experience that they can test positive for THC while being functionally unimpaired, the result is precisely the credibility collapse the Committee warned about. The law's dishonesty about measurement becomes the public health system's dishonesty about risk — and the users who recognise the dishonesty extend their scepticism to every other claim those institutions make, including accurate and important ones. Data from the Colorado Department of Transportation does not support the assertion that impaired driving-related serious injuries are increasing — in fact, its 2017 Problem Identification Report shows that the percent of cases where an officer suspected drugs or alcohol in a serious-injury crash decreased slightly or remained stable after legalisation. Per se THC laws are not just scientifically indefensible. They are actively counterproductive to the credibility infrastructure that honest drug education requires. --- ## PART SIX: SYNTHESIS — THREE OMISSIONS, ONE IMPERATIVE The three structural omissions identified in this paper are not independent failures. They constitute a single, coherent system of policy error — one in which each omission reinforces the others, and in which prohibition is the common root cause. **The pre-drive decision omission** — the failure to account for the fact that cannabis largely preserves the metacognitive capacity to choose not to drive, while alcohol systematically destroys it — produces a policy framework that cannot explain why combined use is more dangerous than either substance alone, and cannot design interventions targeted at the moment when driving decisions are actually made. **The displacement omission** — the failure to account for the documented finding that cannabis typically substitutes for alcohol at the population level, with measurable road safety benefits — produces a public health discourse that treats cannabis as a pure incremental risk, when the evidence repeatedly suggests it is, for a significant proportion of users, a *substitution* risk — one that, when understood honestly, points toward net harm reduction rather than net harm increase. **The credibility omission** — identified by the New Zealand Health Select Committee in 1998 and reiterated in every jurisdiction where drug education built on worst-case scenarios has failed to influence typical user behaviour — produces a communication system that is structurally prevented from telling the truths that would actually protect people, because those truths require acknowledging distinctions that prohibition demands be erased. Together, these three omissions describe not merely a policy failure, but a public health failure — one in which the people most at risk from cannabis-alcohol combination use are the least likely to receive accurate information about why that combination is dangerous, because the system that should inform them has forfeited its credibility by pretending the distinction between the two substances does not exist. --- ## PART SEVEN: IMPLICATIONS FOR DRUG POLICY REFORM ### 7.1 — A Policy Framework That Includes the Displacement Effect A drug policy framework that honestly integrates the substitution evidence would: - Acknowledge that for a significant proportion of adult users, cannabis and alcohol compete for the same consumption occasions — and that this competition, where it results in substitution, produces road safety benefits that policy has systematically failed to model. - Design public messaging that communicates the specific danger of combination use, grounded in the explanation of *why* it is dangerous — because alcohol eliminates the metacognitive and behavioural caution that cannabis alone preserves — rather than the blanket equivalence messaging that tells users nothing they can act on. - Invest in research that identifies the individual and contextual predictors of substitution versus complementarity, so that interventions can be targeted at the populations where complementarity — and therefore combined-use risk — is most likely. ### 7.2 — Restoring Credibility as a Public Health Imperative The New Zealand Health Select Committee's 1998 diagnosis remains the most politically underutilised insight in the history of cannabis policy reform. Its implication is not that drug education should be abandoned, but that it should be rebuilt on a foundation of honesty — the kind of honesty that treats audiences as capable of processing nuance, that acknowledges what the evidence shows and what it does not, and that does not require prohibition-driven exaggeration to justify itself. Advocacy for reform of cannabis prohibition suggests that prohibition is a failed endeavour, part of the global, century-old 'anti-drug' crusade driven by the international drug control regime. The MildGreens Initiative does not adopt this framing wholesale — the evidence on cannabis harms is real and must be communicated. But the finding that the prohibition framework has systematically undermined the credibility of that communication is not an advocacy claim. It is an empirical one, supported by the record of what drug education built on worst-case scenarios has failed to achieve. Current laws were making criminals out of people when harmful drug use needed to be treated as a health issue. Under harm-reduction models, commercial supply and trafficking of drugs would still be addressed, but people caught with drugs for their own use would not face criminal penalties. A public health framework that decouples cannabis education from criminal enforcement, and grounds that education in the full weight of the neurobiological and epidemiological evidence — including the evidence on substitution, on pre-drive decision-making, and on the specific dangers of combination use — would be more protective, more persuasive, and more honest than anything prohibition has permitted. ### 7.3 — Toward Impairment-Based Enforcement and Honest Measurement The path forward on enforcement is clear from the evidence: impairment-based assessment must replace blood-level proxies. Development of technology that expands law enforcement's capacity to evaluate drivers for actual cannabis impairment could also aid individuals in making safer decisions — reflecting a fundamentally different model than the external override framework built for alcohol, and one that respects the retained metacognitive capacity that cannabis users typically preserve. Public health campaigns should emphasise clear guidelines on how long to wait after cannabis use before driving, rather than relying solely on self-assessed intoxication — practical information that addresses the information deficit without fabricating a metacognitive failure analogous to alcohol's. More restrictive alcohol policies and cannabis policies were both associated with reduced odds of motor vehicle crash fatalities involving their respective substances, with a 10-percentage point increase in cannabis policy robustness associated with reduced odds of cannabis involvement in crash fatalities. Evidence-based policy, carefully designed, protects people. Evidence-free policy, dressed in the language of protection, does not. --- ## CLOSING STATEMENT FROM THE MILDGREENS INITIATIVE The New Zealand Health Select Committee understood something in 1998 that drug policy has spent the subsequent quarter-century failing to act on: that the credibility of drug education is not separable from the honesty of drug policy. You cannot build a trustworthy communication system on a foundation of neurobiological inaccuracy, legal frameworks that criminalise residue rather than impairment, and messaging that treats the worst-case scenario as the representative one. The three structural omissions this paper identifies — the pre-drive decision, the displacement effect, and the credibility crisis — are not separate policy failures. They are the same failure, expressed in three different domains. And the common cause of all three is the same: a prohibition framework that required cannabis to be presented as neurobiologically equivalent to alcohol, legally equivalent to far more harmful substances, and educationally approachable only through worst-case framing — regardless of what the evidence said, and regardless of what users knew from their own experience. The most dangerous moment in impaired driving is not when the impaired person changes lanes. It is when the person who is about to become impaired decides which substance to consume, in what combination, and whether they will drive afterward. That decision is shaped by what they know — and what they know is shaped by what they have been told. If what they have been told is neurobiologically illiterate, their decision will be made in the dark. The displacement evidence tells us that many people, left to their own devices, already make the intuitively safer choice. The task of credible drug education is not to override that intuition with worst-case exaggeration. It is to *inform* it — with honesty about combination risks, about timing, about the specific ways in which alcohol corrupts the very faculties that cannabis largely preserves. That is what the evidence demands. That is what the New Zealand Select Committee called for. That is what a quarter-century of prohibition-distorted drug education has not delivered. The reform is not only about law. It is about truth. And truth — in public health, as everywhere else — is the only foundation on which anything protective can be built. --- *The MildGreens Initiative is an independent research and advocacy body committed to evidence-based cannabis policy reform. This document is compiled from peer-reviewed literature, epidemiological data, and ongoing clinical research. It is intended for policymakers, researchers, legal professionals, and informed members of the public.* *© MildGreens Initiative | Research Position Paper Series — Third Edition* *This document may be freely reproduced with attribution.* --- **KEY REFERENCES (Abbreviated)** - Health Select Committee (1998) — *Inquiry into the Mental Health Effects of Cannabis*, GP Print, Wellington - Risso et al. (2020, *Journal of Psychopharmacology*) — Cannabis as substitute or complement for alcohol: systematic review - Reiman et al. (2009, *Addiction Research & Theory*) — Cannabis as substitute for alcohol and other drugs: British Columbia dispensary survey - Lucas et al. — Cannabis substitution for alcohol within Canadian managed alcohol programmes (*Drug and Alcohol Dependence*, 2025) - Anderson et al. — Recreational cannabis legalisation and alcohol purchasing: difference-in-differences analysis (*Journal of Cannabis Research*, 2021) - IIHS — Medical marijuana laws and traffic fatality rate reductions - ScienceDirect (2025) — Cannabis administration and reduced alcohol consumption: laboratory co-administration paradigm - Steele & Josephs (1990) — Alcohol Myopia Theory - Fitzgerald et al. (2025, *Clinical Chemistry*) — Per se THC statutes and abstinence-period blood concentrations - MPP.org — Marijuana and DUI Laws; Colorado post-legalisation traffic safety data - McCartney et al. — Systematic and meta-analytic review of THC-induced driving impairment - AAA Foundation for Traffic Safety — THC per se law evaluation

ELEVEN THOUSAND REASONS TO RETHINK PROHIBITION

2026-06-15T11:09:42.096+12:00

MEDIA RELEASE

MildGreens Initiative: For immediate release — 15 June 2026

ELEVEN THOUSAND REASONS TO RETHINK PROHIBITION

New Zealand's all-time record prison muster is not a crime story — it is a drug policy story

CHRISTCHURCH — New Zealand's prison population reached 11,255 as at 31 March 2026, the highest in the nation's recorded history. The MildGreens Initiative says the Government's framing of this crisis as a law-and-order success story is a profound misreading of the data — and of fifty years of compounding policy failure.

The March 2026 quarterly statistics from the Department of Corrections confirm what drug policy analysts have long argued: the prison muster is not merely a reflection of crime; it is a direct artefact of how the state chooses to respond to drug use. The Misuse of Drugs Act 1975 — unchanged in its prohibitionist architecture — continues to be the single largest structural driver of imprisonment in Aotearoa, not through drug convictions alone, but through the cascade of harms its market conditions generate.

The numbers the Government is not telling you

The official offence-type breakdown records drug offences as the primary charge for a comparatively modest share of the sentenced population. This framing is deliberately — if perhaps not intentionally — misleading.

It counts only those for whom a drug charge is the most serious recorded offence. It does not count the methamphetamine-dependent person imprisoned for burglary. It does not count the gang associate imprisoned for assault in a turf dispute over a market that prohibition created and maintains. It does not count the woman on remand for receiving stolen property to fund a habit that an unregulated supply chain has made prohibitively expensive. Every one of those people is, in a meaningful policy sense, a prisoner of prohibition.

Apply the fuller accounting, primary drug offences, acquisitive crime driven by drug dependence, violence generated by illicit market dynamics, and remand inflation driven by surging drug charges — and credible estimates place between one quarter and two-fifths of the current muster as prohibition-consequential. At the March 2026 population of 11,255, that is a lower-bound estimate of 2,800 to 4,500 people whose imprisonment traces directly to the policy choices made in 1975 and maintained, with incremental cruelty, ever since.

The spike is not organic — it is operational

Ministry of Justice data released in September 2025 recorded 8,474 drug possession and use charges for the year to June 2025, the highest in a decade. In 2025, 3,158 people were convicted of unlawful possession or use, and nearly two-thirds of all drug convictions were for possession or use as the most serious offence. For 465 people imprisoned in 2024/25, drug use or possession was their only charge. A 40 percent year-on-year increase.

The Ministry's own report notes that the spike in drug charges appears to be operationally driven — Police activity, not a change in the law or any meaningful change in use patterns. Wastewater surveillance data confirms drug use is at record levels. The enforcement surge is not reducing consumption. It is increasing imprisonment.

The NZ Drug Foundation has been direct: "Criminalising people clearly doesn't deter use. What it does do is compound some of the worst drug harms by preventing people from seeking help and putting people through the justice system."

This is not a new observation. It has been made, with supporting evidence, for five decades.

The structural logic of a failing system

The 1975 Act was not designed around evidence of harm. It was designed around a moral architecture of prohibition, a framework imported wholesale from international conventions drafted in the political climate of the 1960s, with minimal attention to the pharmacology of the substances it classified or the social conditions of those most likely to use them.

The MildGreens Initiative has documented, across nearly two decades of public commentary, the recursive failure of this architecture. Prohibition does not reduce drug availability. It does not reduce drug use. It does not reduce drug harm. What it reliably does is:

Transfer the drug supply to unregulated, criminal markets
Inflate prices, driving dependent users into acquisitive offending
Generate market violence among competing suppliers
Criminalise predominantly poor, Māori, and marginalised populations
Consume Police, court, and corrections resources at enormous public cost
Prevent people from seeking help by attaching criminal stigma to drug use

Māori are the living evidence of this systemic failure. They are twice as likely to receive a prison sentence as non-Māori following conviction. They are disproportionately represented in every drug prosecution cohort. The prohibition framework does not fall equally; it is administered, in practice, as a racialised enforcement regime.

The cost that never appears in the Budget

The coalition government's own projections forecast the prison population rising to 14,230 by June 2035 — a 36 percent increase from February 2025. Treasury has identified the growing remand population as a key cost pressure. The Department of Corrections' current annual budget exceeds $2.5 billion.

No serious accounting of that $2.5 billion asks how much of it is the direct cost of maintaining a drug policy that the evidence has long since condemned. No Minister has been required to answer that question in the House. No Select Committee has examined it. The Misuse of Drugs Act 1975 continues to function as a legislated off-ramp for political accountability.

The MildGreens Initiative notes, with some weariness, that these observations are not novel. They were made in the Hansard debates of 1975. They were made when New Zealand's Restricted Substances Regulations 2008 offered a biopsychosocially grounded alternative framework that Parliament declined to extend. They were made in the evidence presented to the Canadian Senate in 2009. They were made in the lead-up to the 2020 cannabis referendum. They continue to be made, and continue to be structurally ignored.

What the record muster tells us

An all-time high prison muster is not a sign that the system is working. It is a sign that the system is consuming itself. A state that responds to a public health crisis with a criminal justice mechanism will always produce more prisoners. It will not produce less drug harm.

Eleven thousand two hundred and fifty-five people in custody on 31 March 2026 is not a success metric. For the thousands among them whose imprisonment traces to the drug market this Government maintains through the Misuse of Drugs Act 1975, it is a consequence, chronic, systemic, and entirely foreseeable.

The MildGreens Initiative calls on the Government to:

Commission an independent audit of the proportion of the current prison muster that is directly or proximately attributable to drug prohibition — including primary drug offences, drug-driven acquisitive crime, and drug-market violence — and make that audit public.
Acknowledge that the Misuse of Drugs Act 1975 is not fit for purpose as a public health instrument or as a criminal justice framework, and commit to a comprehensive legislative review grounded in harm minimisation principles.
Restore and extend the biopsychosocial regulatory framework established under the Misuse of Drugs (Restricted Substances) Regulations 2008, as a basis for evidence-based differentiation between drug categories rather than blanket prohibition.
End the operational enforcement surge targeting drug possession and use, which is demonstrably increasing imprisonment without reducing drug harm.

The prison gates will not close on this crisis until the policy gates open.

ENDS

For further comment: Blair Anderson MildGreens Initiative mildgreens.blogspot.com | mildgreens.wordpress.com Christchurch, Aotearoa New Zealand

The MildGreens Initiative has advocated for evidence-based drug policy reform since the late 1990s. Blair Anderson was a co-architect of New Zealand's Misuse of Drugs (Restricted Substances) Regulations 2008 and co-founder of Educators for Sensible Drug Policy (EFSDP). He presented New Zealand's restricted substances regulatory framework to the UN Office of Drug Control, Vienna, 2018 and Canadian Senate Standing Committee on Legal and Constitutional Affairs in 2009.

Sources: Department of Corrections, Prison Facts and Statistics March 2026; Ministry of Justice Criminal Conviction and Sentencing Statistics 2024/25; NZ Drug Foundation media release, March 2026; Justice Sector Projections 2025.

Blair Anderson

Social Ecologist 'at large'
http://blairformayor.blogspot.com

http://facebook.com/mildgreens
http://mildgreens.blogspot.com
http://efsdp.org

Christchurch, New Zealand
nz cell 021 823647

GW Pharmaceuticals and Dr David Hadorn

2026-06-15T10:57:01.728+12:00

https://share.google/aimode/CgZAm32jM7BLU77r0

2026-06-02T11:59:55.645+12:00

Alcohol's propensity to interfere with lipid fats may well be a clue as to endocannabinoid efficacy and impediment, suggesting cannabis doesn't mask early onset damage from the earliest immune system response, whereas alcohol does, it initiates, masks protective pathways and is thus co-inflammatory. The dose response is not linear. The social nexus behind alcohol availability, its association with all things good is disproportionally represented when, aside from the biological impact it carries a massive social burden for its psychoactive impacts, short and long term.

Cannabis is not responsible for any of this.

Alcohol's social burden is more than half the **vote. You wont find that in the 'budget'.

UK NHS estimates it to be 70%.

Blair Anderson http://mildgreens.blogspot.com

Anderson vs Electoral Commission's Conduct.

2026-06-02T08:55:37.532+12:00

Anderson vs Electoral Commission's conduct.

What is the lexical difference and subjective interpretation of the two phrases?

You are voting on the End of Life Choice Bill and cannabis

You are voting on the End of Life Choice Bill and Cannabis Legalisation and Control

Why would I ask this question? For that answer, the former wsa published by the Electoral Commission, whereas the latter, when examined lexically, evidences the obsfucational difference between what was argued as being of no consequence and what was denied examination when the Electoral Commission stymied the Referendum's legislated checks and balances initiated at the Christchurch High Court, by>300 petitioners.

First, the context:

Yes — the conduct of the cannabis referendum was indeed challenged. Here's what happened:

The High Court Petition

A group of more than 330 electors filed suit against the Electoral Commission in the High Court of New Zealand seeking to have the results of the cannabis referendum dismissed.

Under the Referendums Framework Act 2019, groups of 200 or more electors who are "dissatisfied with the result of the referendum" are empowered to petition the High Court to inquire into the conduct of the referendum or those associated with it.

What They Argued

Blair Anderson, one of the petitioners who advocates drug reform, emphasised that "it's not the result of the referendum we're disputing, we're disputing the conduct of that referendum." The petitioners' complaints also included misinformation in the mainstream media going uncorrected, criticism of the NZ Medical Association's stance and coverage, and concerns about media coverage given to the 'No' advocates and the veracity of their statements going unchecked.

How Narrow the Legal Bar Was

The actual grounds on which a court can revisit a referendum result are much narrower than the legislation might suggest, because the process mirrors the "election petition" process under the Electoral Act 1993, concerned with corrupt or illegal practices, issues directly affecting the outcome, counting of votes, or the conduct of Returning Officers.

The petition it was asserted didn't appear to allege any direct wrongdoing in the referendum process itself rather, complaints about misleading ads (some of which had passed the Advertising Standards Authority), the Electoral Commission's response to those ads, and media coverage.

Expert Assessment

Professor Andrew Geddis of the University of Otago wrote that "this legal challenge to the referendum stands no chance of success in court" and highlighted vagueness in the petitioners' allegations.
(Andrew did not question the relevance of the failure to provide security, the core issue before the court's final decision in favour of the Electoral Commission, and didn't address the right to bring the Referendum review due process... )

If It Had Succeeded

If the petitioners had been successful in getting the High Court to declare the cannabis referendum void, the Act would have required a new referendum to take place within six months of the declaration.

There's no record of the court ultimately ruling out the petitioners' favour, consistent with the legal commentary at the time that the challenge faced very long odds. 

The "No" result stood, and the government indicated it had no plans for further cannabis law reform.

So.... what is this post really all about?

While both the  phrases clearly refer to the same event, most notably the referendums held during the 2020 New Zealand general election, the way they are phrased creates distinct lexical (vocabulary and grammar) and subjective (psychological and framing) differences. The Electoral Commision argued to Justce and Electoral  Select Committee Review they meant and were the same... and brevity was required due to lack of room.

Here is an analysis of how the two phrases differ.

1. Lexical Differences
Lexical differences refer to the specific words chosen, their grammatical function, and their level of specificity.

Noun vs. Compound Noun Phrase:

Phrase 1 uses the isolated, common noun "cannabis" (with a lowercase 'c').

Phrase 2 uses the capitalised compound phrase "Cannabis Legalisation and Control."

Action and Scope:

Phrase 1 omits any words that describe what is happening with the cannabis. The phrase "voting on... cannabis" lacks an action word regarding the substance itself.

Phrase 2 includes two explicit policy nouns: "Legalisation" (changing the legal status) and "Control" (implementing a regulatory framework).

Symmetry and Formality:

Phrase 1 creates an asymmetrical sentence structure. "End Of Life Choice Bill" is highly specific and formal, while "cannabis" is broad and informal.

Phrase 2 creates lexical symmetry. "Cannabis Legalisation and Control" sounds like the formal title of a bill or a specific ballot measure, matching the formality of the "End Of Life Choice Bill."

2. Subjective Interpretation
Subjective interpretation deals with how a reader or voter psychologically receives and processes the information. The different wording triggers different associations, assumptions, and emotional responses.

Phrase 1: "...and cannabis"

Ambiguity and Guesswork: Because the phrase lacks specificity, the reader must fill in the blanks. A reader might subjectively ask, "What about cannabis? Are we voting to ban it? To decriminalize it? To allow it for medical use?"

Focus on the Substance: By isolating the word "cannabis," the phrase directs the reader's attention strictly to the plant/drug itself. This can bypass thoughts of policy and directly trigger the reader's pre-existing personal, moral, or cultural biases regarding drug use.

Phrase 2: "...and Cannabis Legalisation and Control"

Clarity and Intent: The reader is not left to guess the nature of the vote. The subjective takeaway is that the ballot will result in a specific legislative outcome.

The "Control" Framing: The inclusion of the word "Control" is a highly effective subjective framing tool. For voters concerned about public health or safety, "control" implies age restrictions, taxation, quality assurance, and regulation. It shifts the mental image away from an unregulated free market and toward a structured government policy.

Focus on the Framework, Not Just the Substance: By adding the words "Legalisation and Control," the reader's subjective interpretation shifts from the substance itself (the drug) to the legislative framework (the rules governing the drug).

Summary
In short, Phrase 1 is colloquial, ambiguous, and directs the reader's mind to the raw subject matter, requiring them to assume the nature of the vote. Phrase 2 is formal, precise, and directs the reader's mind to a specific regulatory framework, framing the vote as a choice about legislation rather than just a choice about a substance.

/Blair Anderson, 
Another MildGreen Initiaitive
Christchurch.
021823647

Blair Anderson

The situation I am referring to touches on the complexities of electoral design, voter psychology, and institutional accountability.

In the 2020 New Zealand general election, the Cannabis Legalisation and Control referendum failed by a very narrow margin, approximately 50.71% voting "No" to 48.43% voting "Yes" (a difference of roughly 24,000 votes).

When an electoral body like the Electoral Commission argues to a parliamentary committee that a simplified phrase ("voting on cannabis") is functionally identical to the formal title ("Cannabis Legalisation and Control") and had no influence on such a tight result, it carries several significant implications for democratic processes:

1. The Debate Over the "Voter Mandate"

In a referendum with a ~1.5% margin, the subjective interpretation of the language becomes highly consequential.

The Proponents' View: If the public largely used or understood the phrase "voting on cannabis," proponents of the bill could argue that voters were rejecting the *general concept* of the drug due to moral or health concerns, rather than rejecting the *specific regulatory framework* of the Bill itself.

The Commission’s Implication: By arguing the phrases are identical, the Electoral Commission is essentially asserting that the public's understanding was accurate and that the mandate is clear: the public rejected the legislation and control as presented.

I am arguing that dismissing the linguistic difference minimises the argument that ambiguity in public discourse cost the "Yes" side the election. And that is a matter of considerable substance.

2. Accessibility vs. Legislative Precision

Electoral commissions worldwide constantly grapple with a tension: should a ballot or public communication be highly precise (like a legal document), or easily digestible (for the average voter)?

The Institutional Defense: The Commission argued that "cannabis" and "Cannabis Legalisation and Control" mean the same thing to the average voter because they prioritise accessibility. To an institution, simplifying language prevents voter confusion and lowers the barrier to civic participation.

The Risk in Tight Races: The implication of this stance is that it underestimates the impact of "framing effects." In a landslide election, linguistic nuances do not matter. But in a race decided by 1%, the omission of words like "Legalisation and Control" (which imply safety, taxation, and age restrictions) might leave undecided voters to fill in the blanks with worst-case-scenario assumptions, or not vote at all.

3. Impact on Institutional Trust

How an electoral body responds to post-election scrutiny has a direct impact on public trust.

For the Winning Side: The Commission's stance provides reassurance to those who voted "No." It reinforces the validity of their vote and defends the integrity of the election process against claims of systemic bias or inadequate voter education.

For the Losing Side: Conversely, if the "Yes" camp feels that the Electoral Commission's simplified messaging inadvertently allowed misinformation to spread (e.g., voters thinking legalisation meant unregulated free use), the Commission dismissing their concerns as "having no influence" can feel alienating. It risks making the losing side feel that the institution is defensive rather than reflective.

4. Setting Precedents for Future Referendums

The Commission's argument to Parliament sets a precedent for how future referendums are designed and defended.

If an electoral body establishes that colloquial shorthand is acceptable and distinct from the actual legislative title, it implies that future campaigns and public communications do not need to rigorously adhere to exact legislative phrasing.

However, the closeness of the cannabis vote acts as a significant cautionary tale. It suggests that in future referendums on complex social issues, the gap between the "simplified concept" and the "complex legislation" must be actively bridged by robust, taxpayer-funded public education campaigns.

If the Commission relies on the assumption and assertion (as is a matter of record the Justice and Electoral Select Committee considerations) that voters naturally equate the shorthand with the formal title, a close margin reveals the danger of that assumption.

Summary

Ultimately, the Electoral Commission’s argument that the phrasing had no influence is an attempt to protect the integrity of the referendum result.

However, the implications of that argument in a razor-thin margin highlight a fundamental vulnerability in direct democracy: when a vote is this close, the gap between colloquial shorthand and the legislative reality was wide enough to alter the outcome, leaving the true intent of the electorate vote open to perpetual debate.

The Electoral Commission's rejection of the 'right to the 200+ petitioners' to exercise both subjective and objective inquiry by roadblocking the legislative enabled remedy and High Court's oversight, is in effect a grave error in its fecund duty to self examine its own conduct and by crucial omission, fail to reveal this to the Justice and Electoral Committee.

Blair Anderson,

Another MildGreen Initiative

021823647

Blair Anderson

Given that statutory rights (to review the referendum) exist on paper, expert commentary deems them unviable, procedural barriers prevent a hearing, and the enabling legislation is left with no jurisprudential meaning at all.

How safe is the continuing political discourse that holds that 'No Won, Yes Lost' and no further discussion is warranted as the debate is resolved?

The statement "No Won, Yes Lost debate resolved" is a political proposition dressed as a legal one, and the distinction matters enormously.

Democratically speaking, a binary vote resolves a question at a point in time, under specific electoral conditions, with a specific franchise, on a specific question as framed. It does not and legally cannot permanently extinguish:

The right of political argument (a fundamental democratic liberty)

The right to seek legislative change through subsequent Parliamentary processes

The right to revisit a question where material circumstances have changed

The right to challenge procedural unfairness in the original process

If statutory review rights exist and are rendered meaningless, then the claim that the democratic process is "complete and closed" is actually undermined by the very statute that authorised the referendum, because that statute, by providing for review, acknowledged that the process might not be above challenge.

/Blair Anderson

Blair Anderson

Crown Law's Role.

Crown Law argued the petitioners had failed to meet the security deposit requirement "in time." The ethical dimension here warrants attention.

Crown Law is not merely a private law firm, it acts as counsel for the Crown and must conduct itself consistent with its obligations as an administrator of justice and with the Crown's duty to act fairly.

Where Crown authority is exercised in relation to a statute, the terms of the statute are pre-eminent, and the statutory "real justice" mandate under the Electoral Act bears directly on how the Crown, as respondent, could legitimately run procedural arguments. [Nzlii]

If Crown Law was aware, or ought to have been aware, that the petitioners had received official advice that the deposit was not required, advancing a submission that exploited that exact gap would be difficult to reconcile with the Crown's special obligations as a litigant.

The Crown is not a private litigant entitled to take every advantage.

It has an obligation to assist the Court to do justice, not to ambush lay petitioners with procedural technicalities induced by the Court's own staff.

3w
Reply
Edited

Blair Anderson

Since the finding that the petitioners failed to provide security.... consider:

"A court asked to dismiss a petition for non-payment of a deposit that its own staff said was unnecessary would face serious difficulty doing so without offending basic principles of justice" — is, if anything, an understatement.

The difficulty is not merely one of optics. It is a structural violation of the principle that no party should be prejudiced by official misinformation given by the very institution whose process they are navigating.

Warren Bryson

the answer to me is that andrew effin Little was put in charge and he did his damnest to make subtle wording confuse and put f'all Little money into an fair and unbiased education campaign on the meaning and options. then we had the dictator who was running the medical assoc Kate Badcock badmouthing the truth, pretending she was speaking on behalf of all medical professionals when she said people should vote NO then we had.... sorry my fingers will be stubbs if i list them all...

Warren Bryson

Heres some more bullshite masquerading as a 'balanced ' article 1 month out from the date....https://theconversation.com/undecided-on-the-cannabis-referendum-10-pros-and-cons-of-legalising-the-drug-146399

3w
Reply
Edited

Blair Anderson http://mildgreens.blogspot.com

Landmark Study Challenges Referendum Disinformation: Cannabis Users Show Enhanced Brain Function

2026-04-26T00:24:21.195+12:00

MildGreens - Drug Policy Reform Aotearoa New Zealand

FOR IMMEDIATE RELEASE 25 April 2026

Landmark Study Challenges Referendum Disinformation: Cannabis Users Show Enhanced Brain Function/

MildGreens calls on Parliament to revisit the 2020 Cannabis Legalisation and Control referendum in light of new USA federally-funded evidence that directly contradicts the cognitive harm claims used to defeat reform.

A major new study funded by the United States federal government, the largest of its kind, has found that cannabis users demonstrate superior performance across multiple cognitive domains, and that their brains exhibit characteristics typically associated with younger individuals.

The findings, published in August 2025 as a preprint by Nature Portfolio, represent a direct and evidence-based challenge to the narrative of cognitive harm that shaped New Zealand's 2020 referendum on Cannabis Legalisation and Control.

What the Science Shows: Analysing brain imaging and cognitive assessment data from 37,929 UK Biobank participants aged 44–81, researchers from the Georgia Institute of Technology, Emory University, University of Colorado and partner institutions found that cannabis users consistently outperformed non users across a battery of cognitive tests.

The study concluded that cannabis use may be associated with a deceleration of neural ageing processes, with cannabinoids and endocannabinoids potentially exerting neuroprotective effects in older adults. The researchers identified brain network patterns in cannabis users that are "typically associated with younger brains," pointing to a potential modulatory role for cannabinoids in neurodegenerative processes.

These benefits were observed from midlife into the late 60s and beyond, precisely the demographic most relevant to chronic health-related cannabis use in Aotearoa. This study adds to a growing body of peer-reviewed evidence, including:

• A 2024 study finding cannabis users report significantly lower rates of subjective cognitive decline, including reduced confusion and memory loss.

• A 2023 study finding that prescribed medical cannabis has minimal acute impact on cognitive function in patients with chronic health conditions.

• An American Medical Association study of over 63 million health insurance beneficiaries finding no statistically significant increase in psychosis-related diagnoses in legalised jurisdictions.

• Research from 2018 indicating cannabis may improve working memory and does not alter brain structure.

Disinformation and the 2020 Referendum

The 2020 Cannabis Legalisation and Control Bill referendum was narrowly defeated, with 53.4% of New Zealanders voting against reform. The No campaign relied heavily on claims that cannabis causes significant cognitive harm, psychosis, and long-term brain damage, messaging that the MildGreens and allied advocates identified at the time as inconsistent with the scientific literature and rooted in decades of prohibition-era disinformation.

Blair Anderson, spokesperson for MildGreens, says the accumulation of evidence since the referendum strengthens the case that New Zealand voters were not given an accurate picture of cannabis risk: "The referendum was lost on fear, not fact. The cognitive harm thesis was the cornerstone of the No campaign.

A federally funded study of nearly 38,000 people now shows not only that the harm was overstated, but that the relationship between cannabis and cognition may be the inverse of what was claimed."

MildGreens notes that this pattern is consistent with the legacy of the 1974 Misuse of Drugs Act and the international drug control treaties to which New Zealand remains a signatory to frameworks built not on pharmacological evidence, but on moral panic and racial politics.

As Māori continue to be disproportionately policed, prosecuted and imprisoned under cannabis prohibition, the human cost of evidence-free policy-making remains acute.

A Call for Legislative Review

MildGreens is calling on Members of Parliament, the Health Select Committee, and the Ministry of Health to:

• Commission an independent review of the scientific evidence base used to inform the 2020 referendum public information campaign.
• Acknowledge that key claims made by the No campaign — particularly regarding cognitive impairment are contradicted by current peer-reviewed science.
• Initiate a new parliamentary inquiry into cannabis law reform, free from the disinformation that undermined the integrity of the referendum process.

• Engage directly with the endocannabinoid research literature as part of any review of the Misuse of Drugs Act 1975.

• Apply a Tiriti o Waitangi lens to the racially disparate impacts of ongoing cannabis criminalisation.

"New Zealand can no longer afford to make drug policy in the dark," Anderson said. "When the United States federal government funds research that overturns the cognitive harm narrative, it is incumbent on our lawmakers to respond. The integrity of the democratic process demands no less." ENDS

Media Contact Blair Anderson, MildGreens, Christchurch Cell: 021823647 Web: mildgreens.blogspot.com facebook.com/mildgreens

Notes to Readers: The study referenced is: "Cannabis Use is Associated with Enhanced Cognitive Abilities and Younger-like Brain Network Organization in Older Adults" (2025), published as a Nature Portfolio preprint (Research Square, rs-6977015/v1). Supported by National Science Foundation and National Institutes of Health grants. Authors are affiliated with the Georgia Institute of Technology, Emory University, Georgia State University, University of Colorado, University of Chinese Academy of Sciences, and the Tri-Institutional Center for Translational Research in Neuroimaging and Data Science.

MildGreens is a Christchurch-based drug policy reform initiative founded by Blair Anderson. It has advocated for evidence-based cannabis policy in Aotearoa New Zealand since 2003 and maintains affiliations with international reform bodies including LEAP (Law Enforcement Against Prohibition), Educators For Sensible Drug Policy (co founder) http://efsdp.org

Blair Anderson http://mildgreens.blogspot.com

Canada’s cannabis industry contributes more than $76 billion to Canada’s GDP, generates nearly 100,000 jobs annually

2026-04-26T00:16:43.095+12:00

Sharing this StatCan article with you.

https://www.statcan.gc.ca/o1/en/plus/6091-cannabis-consumption-canada

Scripted End Game or Cause Celebre, Legend and Crucading Saviour.

2026-03-27T12:13:00.000+13:00

How history will tell how peace was achieved....

Blair Anderson

Social Ecologist 'at large'
http://blairformayor.blogspot.com

http://facebook.com/mildgreens
http://mildgreens.blogspot.com
http://efsdp.org

Christchurch, New Zealand
nz cell 021 823647

2026-03-15T04:30:00.002+13:00

Canada's Cannabis Regulatory Model (2018–2024): The Social Dividend

When Canada legalised recreational cannabis in 2018, the world watched closely — and by 2024 the numbers told a powerful story: the legal sector added $76.5 billion to Canada's GDP. Mycannabis The industry sustained approximately 98,200 jobs annually across the country and generated $28.7 billion in cumulative sales over six years, with recreational products accounting for nearly 87%. StratCann

The tax impact was enormous — the industry generated $29.6 billion in government revenue across Canada between 2018 and 2024, drawn from sales and excise taxes as well as direct, indirect, and induced tax contributions from producers, retailers, and employees. The Marijuana Herald From a standing start, annual legal cannabis sales grew to $16 billion in 2024 GDP contribution alone, supporting over 227,000 jobs that year. Born2Invest

Critically, the proportion of Canadian adults obtaining cannabis from the illicit market dropped from 86% in early 2019 to approximately 30% by 2022 — with legalization producing a large reduction in arrests and convictions for cannabis use. PubMed Central Canada's stated rationale was to displace the illicit market, protect youth, and provide adults with a legal source of quality-controlled cannabis — with legalization also lessening the harms of convictions for simple possession and disrupting organised crime's control of the cannabis trade. Canada.ca

New Zealand's 50-Year Prohibition: The Social Burden

Enforcement Costs and the Criminalisation Trap

New Zealand Police spend over 330,000 hours annually on cannabis enforcement, costing taxpayers almost $200 million per year. Wikipedia A BERL study found that police enforcement of cannabis activities cost $116 million in 2005–2006 alone, accounting for 334,000 policing hours — and the cost has only grown since. NZ Drug Foundation

There is a cannabis arrest every 30 minutes on average in New Zealand — approximately 15,000 people arrested on roughly 25,000 cannabis charges annually, with 85% of these for small personal offences. Most crimes that have victims, meanwhile, remain unsolved. Norml

Between 2007 and 2011, New Zealand spent more than $59 million imprisoning those convicted of minor drug offences — imprisonment costs alone, excluding police, courts, legal aid, treatment or probation. NZ Drug Foundation

The $1.5 Billion Black Market and Organised Crime

New Zealand's illicit cannabis market is estimated at NZ$1.5 billion annually, based on 557,000 consumers aged 15 and older purchasing at an assumed price of $20 per gram. MJBizDaily The prohibition of popular commodities creates economic opportunities for those prepared to risk selling on the black market — and enforcement can have the perverse consequence of promoting the most organised and violent criminal groups, as regular policing eliminates those less willing to use violence. The NDIB believes a significant proportion of cannabis cultivation in New Zealand is carried out by organised criminal gangs. MSD

Cannabis is now worth so much money that people are killed over it. Prohibition creates violence and intimidation used to enforce contractual obligations or eliminate competition. Norml Increasing possession of firearms by gangs has increased violence and competition over territories in the drug trade, with demand and price of firearms rising as a result. Around 2020, NZ Police started saying they were dealing with real organised crime for the first time ever. The Organized Crime Index

Human Rights and Racial Disparity

Māori are three times more likely to receive a cannabis conviction than non-Māori at equivalent use levels, are twice as likely to suffer a substance use disorder, and face harder access to health and treatment services. Māori represent approximately 16.5% of New Zealand's population yet make up nearly 40% of those imprisoned for drug offences. Wikipedia

The presumption-of-supply provision — triggered by possession of just 28 grams or 100 joints — was held by the Supreme Court in R v Hansen (2007) to be inconsistent with the Bill of Rights Act's presumption of innocence, yet it remains effective law. Possession of any amount of cannabis is illegal. Wikipedia

The 600,000 Suppressed Consumers and Entrepreneurs

The identified pool of over 600,000 New Zealand cannabis users represents not merely consumers but a class of potential entrepreneurs, cultivators, retailers, and sector workers locked entirely out of the formal economy. They face a cascading set of civil exclusions upon conviction — denial of international travel, professional licensing, mortgage access, insurance eligibility, and employment — consequences wholly disproportionate to the conduct. The Drug Foundation's Sarah Helm has noted that convictions do nothing to deter use, and the majority of the public do not think cannabis use should be a crime — yet hundreds of New Zealanders still face court each month for cannabis possession. The Spinoff

What Legalisation Would Mean for New Zealand

BERL's modelling for the Ministry of Justice found that a legal cannabis industry would employ 5,000 people fulltime, creating $210 million per year in salaries and wages and boosting GDP by $440 million annually. NZ Herald A change in law was modelled to annually generate $335 million in GST, $640 million from excise tax, and a further $440 million from a harm reduction levy — a total of over $1.4 billion in annual public revenue. RNZ Independent research indicates the annual tax intake from cannabis if legalised would be more than $1 billion. Wikipedia

The Drug Foundation's conclusion was unambiguous: a legally regulated cannabis market would add more funding to health and education, reduce convictions and justice system costs, and improve health and social equity outcomes. NZ Drug Foundation

The Verdict

The disparity is stark. Canada used the same substance — the same plant consumed by the same proportion of its population — and converted it from a $200M/yr enforcement liability into a $16B/yr GDP driver. New Zealand, in fifty years of the Misuse of Drugs Act 1975, has achieved the opposite: rising use rates, a more powerful organised crime sector, entrenched racial injustice, and the mass criminalisation of 600,000 otherwise law-abiding citizens whose only distinguishing characteristic is a consumer preference shared by nearly half of all New Zealand adults.

The referendum of 2020 was lost by a margin of 50.7% to 48.4% less than 2 percentage points, often cited as settled democratic authority for continued prohibition. But as columnist Damien Grant noted at the time, the closeness of that vote arguably makes the current prohibition unworkable, not vindicated. Since then, a 2023 poll found that 93.2% of New Zealanders wanted cannabis laws relaxed with 64.2% of those favouring full legalisation. Wikipedia

Canada's model demonstrates that thoughtful, phased legalisation with robust health guardrails is not a "social experiment" it is a proven mechanism for simultaneously reducing crime, raising billions in revenue, creating tens of thousands of jobs, and ending the structural criminalisation of a population that was never a criminal class in the first place.

Blair Anderson http://mildgreens.blogspot.com

How to kill people and pretend someone else did it....

2026-03-15T04:23:45.802+13:00

As signatories to the single convention, NZ citizens may as well be pulling the triggers themselves. The act of doing nothing is complicit sanction.

https://www.facebook.com/share/p/1APUWsHWEN/

Blair Anderson

Social Ecologist 'at large'
http://blairformayor.blogspot.com

http://facebook.com/mildgreens
http://mildgreens.blogspot.com
http://efsdp.org

Christchurch, New Zealand
nz cell 021 823647

Fwd: International Women’s Day: Honoring Leaders in Cannabis Medicine

2026-03-15T04:23:34.903+13:00

Clearly, this quality list of woman, at the cutting edge of cannabis research are, according to Family First just another bunch of Ning Nongs....

Blair Anderson

Social Ecologist 'at large'
http://blairformayor.blogspot.com

http://facebook.com/mildgreens
http://mildgreens.blogspot.com
http://efsdp.org

Christchurch, New Zealand
nz cell 021 823647

---------- Forwarded message ---------
From: Society of Cannabis Clinicians <erin@cannabisclinicians.org>
Date: Mon, 9 Mar 2026, 1:00 am
Subject: International Women's Day: Honoring Leaders in Cannabis Medicine
To: <mildgreens@gmail.com>

Celebrating the Women Advancing Cannabis Medicine

Today, on International Women's Day, we recognize the extraordinary contributions of women clinicians, researchers, scientists, and thought leaders who have helped shape the field of medical cannabis. Their work has advanced scientific understanding, improved patient care, and strengthened the credibility of cannabis medicine within the broader medical and research communities.

At the Society of Cannabis Clinicians, we are fortunate to have worked alongside many remarkable women whose expertise, leadership, and dedication have made meaningful contributions not only to the field of cannabis medicine, but also to the growth and impact of SCC itself. Their efforts continue to help guide clinical practice, expand research, and build a stronger, more compassionate future for patients.

Below, we highlight just a few of the women who have contributed their expertise to SCC programming and to the broader advancement of cannabis medicine.

Deondra Asike, MD

Dr. Deondra Asike is a Clinical Associate in the Department of Anesthesiology and Critical Care Medicine at Johns Hopkins since 2015. She is a veteran of the United States Air Force and earned her medical degree from Georgetown University School of Medicine. She is a licensed acupuncturist in the state of Maryland where she also serves as an advisory board member to the Department of Health's Prescription Drug Monitoring Program. Her area of academic interest includes perioperative considerations for the cannabis consumer.

Bonni Goldstein, MD

Bonni Goldstein, MD is a leading physician, educator, and advocate in the field of cannabinoid medicine. She is the CEO and co-founder of GoldsteinWellness.com, a free medical cannabis educational platform for healthcare professionals, and the Medical Director of Canna-Centers, a medical practice dedicated to the therapeutic use of cannabis for serious and chronic conditions.

Dr. Goldstein completed her residency at Children's Hospital Los Angeles, where she also served as chief resident. After years in pediatric emergency medicine, she transitioned to cannabinoid medicine upon witnessing its profound benefits in an ill friend. Over the past 17 years, she has evaluated thousands of patients and is recognized as an expert in cannabis therapeutics, with a special focus on children with intractable epilepsy, autism, cancer, and other complex conditions.

Dr. Goldstein has co-authored multiple peer-reviewed articles investigating the effects of medical cannabis through pharmacometabolomics, including its impact on autism. She is currently expanding this research to explore cannabis applications in dementia, PTSD and chronic pain.

Dr. Goldstein is the author of Cannabis Revealed, a semi-finalist for the American Botanical Council's 2017 Book of the Year, and Cannabis Is Medicine.

Kirsten Shepard, DC, LMT

Dr. Kirsten Shepard (DC, LMT) is the Founder and CEO of TrueStopper, a holistic health company that leverages professionally-formulated and regenerative hemp-based products to better manage chronic pain and promote whole body wellness. For more than 20 years, she has established integrated practices that combine medical, chiropractic, acupuncture and physical therapy approaches to whole body care, including the opening of clinics across Texas and in Los Angeles. Dr. K's holistic approach to pain relief has led to recognition, by way of awards and teaching opportunities, from Texas legislators and leaders from top hospitals. She is a Cannabis advocate and an active member of Texas NORML, the Minority Cannabis Business Association, the Society of Cannabis Clinicians and a Neil Asher Natural Alternative Therapies (NAT) faculty.

Mary Lynn Mathre, RN

Mary Lynn (ML) Mathre, RN, MSN, CARN is the President and Co-founder of Patients Out of Time, a national non-profit organization dedicated to educating health care professionals and the public about the therapeutic use of cannabis, and Past President and Founding Member of the American Cannabis Nurses Association (ACNA). Mary Lynn graduated from the College of St. Teresa In Winona, MN in 1975 and began her nursing career in the U.S. Navy Nurse Corps. She earned her MS degree from Case Western Reserve University in 1985 and her thesis was on Marijuana Disclosure to Health Care Professionals.

The SCC is proud to be an organization that not only supports women in cannabis medicine, but is also led by them. Today, women serve in key leadership roles across our Board of Directors and staff, helping guide the organization's mission, vision, and continued growth.

If you are interested in joining a community of clinicians and professionals dedicated to advancing evidence-based cannabis medicine, click the link below to become a member. All are welcome!

BECOME A MEMBER

No longer want to receive these emails? Unsubscribe.
Society of Cannabis Clinicians 2001 Santa Monica Blvd STE 1170 Santa Monica, CA 90404

2026-02-18T12:12:00.000+13:00

In Memoriam: Professor Rodney W. Skager (1932-2021) A Pioneer Lost: Remembering the Scholar Who Challenged Drug War Orthodoxy

The harm reduction community lost one of its most influential voices on June 2, 2021, when Professor Rodney W. Skager passed away at his home in Salinas, California, at age 88. His death, after a long battle with Alzheimer's disease, went largely unnoticed outside academic circles—a quiet ending for a man whose work challenged the loudest voices of the War on Drugs.

For more than four decades, Professor Skager stood as a rare academic willing to question the "Just Say No" orthodoxy that dominated drug education policy. As a UCLA Professor Emeritus of Education and former Associate Dean of the School of Education and Information Studies, he possessed the credentials that gave weight to his heresy: that honesty, not fear, should guide how we teach young people about drugs.

Skager's most enduring contribution was his development of harm reduction-based drug education curricula, work that directly challenged the ubiquitous DARE program and zero-tolerance policies of the 1980s and 1990s. As founder and co-director of California's Attorney General Student Survey—a biennial assessment of youth substance use—he built an evidence base that exposed the failures of abstinence-only approaches. His research showed what many parents and educators suspected but few dared say: that teenagers needed accurate information and practical harm reduction strategies, not scare tactics and moral panic.

His 2013 book, Beyond Zero Tolerance: A Reality-Based Approach to Drug Education and School Discipline, offered a comprehensive alternative vision. Rather than punishment and exclusion, Skager advocated for interactive learning, compassionate assistance, and restorative practices. His collaboration with Dr. Marsha Rosenbaum on the Safety First curriculum provided the nation's first harm reduction-based drug education program for high school students, a curriculum that has since been transferred to Stanford Medicine's REACH Lab for further development.

What set Skager apart was not just his scholarship but his moral courage. In an era when questioning drug war dogma could end careers, he persisted. He served as a consultant to the Drug Policy Alliance from 2002 onwards, received the Dr. Andrew Weil Award for Achievement in Drug Education, and continued writing and advocating well into his retirement.

Those who knew him describe a man who "relished" working with students, who championed their causes, and who made education "more personal, meaningful and connected." He was, by all accounts, "a wonderful, caring, kind, respectful, humorous man."

Professor Skager's work laid the foundation for a new generation of drug educators who prioritise student safety over political posturing. His legacy persists in every classroom where teachers provide teenagers with honest, science-based information about drugs, treating them as capable of making informed decisions rather than subjects requiring indoctrination.

The drug education landscape has evolved since Skager entered it over forty years ago, but the questions he raised remain urgent: Do our policies protect young people, or merely punish them? Do we serve their well-being, or our own moral certainties? In asking these questions—and daring to answer them honestly, Rodney Skager embodied the principle that should guide all drug education: First, do no harm.

Professor Skager is survived by his children and the countless students and educators whose work continues his mission of reality-based drug education.

I'm sorry I wasn't able to bring Rod to New Zealand. A rather precious member of the NZ drug policy fraternity, with whom I have serious doubts about their good intentions, besmirched me to Rod, For that reason, he chose not to come. His voice would have been valuable here. I did present copies of his book to Canterbury District Health Board's Community and Public Health Library, they declined itbased on 'cannabis is illegal', and copies I donated to the Christchurch Civic Library didn't appear in their catalogue and when I asked, it was reported that 'they fell down the back of the shelf'. FFS!

Both should be very very embarrassed.

Blair Anderson http://mildgreens.blogspot.com

2026-02-18T12:00:29.534+13:00

idpc.net/publications/2025/08/vienna-after-consensus-report-of-the-68th-session-of-the-un-cnd?fb

Blair Anderson http://mildgreens.blogspot.com

“You can’t police your way out of a policy failure.”

2025-10-13T22:53:00.002+13:00

MildGreens: “New Organised Crime Ministry Is Just Prohibition Rebranded”

Christchurch, 13 October 2025 -

“You can’t police your way out of a policy failure.” The MildGreens are warning that the Ministerial Advisory Group’s final report on organised crime, now before Associate Police Minister Casey Costello, risks becoming the War on Drugs 2.0; a politically repackaged continuation of failed prohibition policies under the banner of “national security.”

“Framing organised crime as a security threat rather than a policy failure is exactly how we got here,” said a MildGreens spokesperson and recent Christchurch mayoral candidate, Blair Anderson, today. “You can’t police your way out of a black market that government itself has created.”

The yet-to-be-released report, chaired by former Crown prosecutor Steve Symon, calls for a new Minister for Organised Crime and a three-year trial structure to combat emerging threats such as cyber fraud, migrant exploitation, and a potential influx of fentanyl.

However, the MildGreens argue that this approach overlooks the root cause.

“Prohibition is the engine room of organised crime,” the group says. “Each decade we get a new scare: meth, fentanyl, gangs, ever stronger pot, and each time the political reflex is more enforcement, more ministers, and more moral panic. Meanwhile, the social drivers of harm go untouched.”

The MildGreens argue that genuine national security depends on sustainable social policy, not securitised bureaucracy.

They point to alternatives that would do far more to undermine criminal networks: (a) Regulating low-risk substances like cannabis under a Class D framework to remove illicit revenue streams. (b)Addressing poverty and housing insecurity, which feed recruitment into gang economies. (c) Improving digital literacy and consumer protection to prevent cyber fraud through education, not punishment. (d) Ensuring public access to evidence, including the immediate release of the full advisory report for democratic scrutiny.

“It’s not fentanyl that threatens our borders, it’s policy inertia,” the MildGreens said. “Organised crime adapts to whatever the law bans. The more we prohibit, the more lucrative we make it.”

The group warns that creating a new ministerial apparatus will simply reinforce institutional silos and divert resources from community-level harm reduction and justice reform.

“If this government truly wants to get ahead of organised crime,” Anderson concludes, “it must shift from prohibition to prevention, from criminalising supply to regulating safety. Until then, this is just the same old War on Drugs with a new business card.”

Contact:

MildGreens Media Office

021823647

Blair Anderson http://mildgreens.blogspot.com

Google Gives Blair’s Brain Back

2025-10-09T02:16:00.003+13:00

by Blair Anderson

Way back when the internet still felt like the Wild West, Google summarily deleted my blog, Blair’s Brain on Cannabis. No warning, no right of appeal — just a curt message about “breaching community standards.”

In an instant, over 1,200 posts — years of drug policy analysis, community engagement, political advocacy, and content from my weekly Plains FM radio show — were gone. It wasn’t just data; it was a record of reform and public conversation erased without due process.

I tried everything — emails, phone calls, digital forms that felt like shouting into a void. The only response was that same faceless phrase: “breached some community standard.” It was the virtual equivalent of “because we said so.”

After months of frustration, I decided if the mountain wouldn’t come to me, I’d go to the mountain.

The Mountain

In Los Angeles, visiting a friend’s storage unit, I noticed a detail in a photo I’d just taken — a distant flag fluttering atop a building. It bore a familiar logo: Google.

The next morning, on the way to meet my friend Jack Herer — the legendary cannabis activist — we passed that same building. I told my friend to drop me off. I had a new plan, half protest, half performance art: if I couldn’t get their attention digitally, maybe I’d “liberate” their flag to make my point.

Clad in my red beret, red jacket, black shorts, and red backpack, I looked like an eccentric mix of activist and cartoon character. I approached the unmarked door that staff were quietly filing through and knocked. Then knocked again.

Eventually, a man appeared — security, I assumed. I handed him my business card and said evenly, “Someone inside needs to know I’m out here.”

“Why are you here?” he asked.

I nodded to the card in his hand. “That,” I said, “is above your pay grade. Google me.”

He blinked, uncertain, then told me to wait.

The Door Opens

About half an hour later, another man appeared — an executive type, all smiles and calm authority. He introduced himself and said, “Your blog will be restored within twenty minutes.”

He explained there’d been a “security issue” with some code I’d uploaded. Possible, maybe, but I wasn’t in the mood to quibble.

I thanked him, stepped back into the California sun, and checked my phone. Sure enough — Blair’s Brain on Cannabis was live again.

The Headline

I sent a press release to The Dominion, New Zealand’s most political daily. The next morning, the headline ran in the computer pages:

“Google Gives Blair’s Brain Back.”

Cute, indeed.

You can still find my resurrected work — the politics, the reform, the passion — at mildgreens.blogspot.com.

And for the record — that red beret? Genuine ETA issue. Not a statement of militancy, just a nod to my Celtic roots — and a warm bit of felt that turned out to be the perfect symbol for stubborn persistence.

Blair Anderson http://mildgreens.blogspot.com

To protect and enhance Christchurch and Canterbury's critical community assets

2025-09-12T00:05:00.000+12:00

I am a mayoral candidate..

I have a clear intersectorial pathway of how to stay ahead of the inevitable. I have prepared an analysis based on my influence, relationship and a three month observational Canadian study and the latest evidence of a NZ$93 billion GDP dividend bringing subsequent outcomes experienced in Canada.

I intend to release it on Sept 16th.

I've developed a comprehensive strategic framework showing how cannabis economic dividends could be systematically applied to protect and enhance Christchurch and Canterbury's critical community assets.

The strategy addresses all your specified community development priorities while projecting a regional cannabis dividend of NZ$620-730 million annually (15% of the national total).

Key Strategic Elements: Asset Protection Focus:

# Christchurch Airport: NZ$100M annually for community ownership transition, climate resilience, and crisis response capability

# Lyttelton Port: NZ$105M annually for earthquake/tsunami resilience and sustainable operations

# Public Transport: NZ$120M annually for light rail, electric buses, and active transport networks

# Housing Assets: NZ$110M annually for community housing and tenant protection

Community Development Integration:

# 4,200+ apprenticeships across infrastructure, green technology, maritime, and manufacturing trades
# Community ownership models preventing asset stripping and ensuring local benefit retention
# Climate adaptation investments future-proofing infrastructure against sea-level rise and extreme weather
# Emergency preparedness enhancing regional self-sufficiency during crises

Democratic Governance:

Regional Asset Trust with community-elected oversight
Neighborhood assemblies for local input
Worker cooperatives for asset operations
Indigenous partnership ensuring meaningful Māori participation

The strategy emphasizes long-term community benefit over short-term profit, creating genuine economic resilience while addressing climate change through systematic emissions reduction (50% by 2030, carbon neutrality by 2035).

This approach transforms the cannabis dividend from simple tax revenue into a foundation for community-controlled sustainable development, positioning Canterbury as a national model for democratic asset management and climate resilience.

Blair For Mayor

--
Blair Anderson
Social Ecologist 'at large'
http://blairformayor.blogspot.com
http://facebook.com/mildgreens
http://mildgreens.blogspot.com
http://efsdp.org
Christchurch, New Zealand
nz cell 021 823647